Bell's palsy

G6_BELLPA

Bell's palsy: Partial or complete paralysis of the facial muscles of one side of a person's face. It is caused by damage to the seventh cranial nerve. It is usually temporary but it may recur.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G51.0 Hospital discharge: ICD-9 — 3510A Hospital discharge: ICD-8 — 350 Cause of death: ICD-10 — G51.0 Cause of death: ICD-9 — 3510A Cause of death: ICD-8 — 350 2 out of 7 registries used, show all original rules.	5880
4. Check minimum number of events None	5880
5. Include endpoints None	5880
6. Filter based on genotype QC (FinnGen only)	5270

Control definitions (FinnGen only)

Control exclude: G6_NERPLEX

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: G51
Name in latin: Paresis nervi facialis

NAME	G6_BELLPA
CONTROL_EXCLUDE	G6_NERPLEX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G510
HD_ICD_9	3510A
HD_ICD_8	350
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G510
COD_ICD_9	3510A
COD_ICD_8	350
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Bell's palsy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	41280	21652	19358
Only index persons	36873	19506	17367
Unadjusted period prevalence (%)
Whole population	0.58	0.62	0.54
Only index persons	0.69	0.72	0.66
Median age at first event (years)
Whole population	51.87	52.85	50.80
Only index persons	50.32	51.08	49.47

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	5270	2979	2291
Unadjusted period prevalence (%)	1.05	1.06	1.05
Median age at first event (years)	54.25	51.71	57.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5484: Matched controls
54840

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G56.0

ICD-10 Finland

Carpal tunnel syndrome

8.6

307.7

609

785

H02.2

ICD-10 Finland

Lagophthalmos

51.3

307.7

193

G51.0

ICD-10 Finland

Bell palsy

17877.7

307.7

5111

H02AB06

ATC

prednisolone; systemic

4.7

307.7

3877

18686

ACC51

NOMESCO Finland

Release of median nerve

69.8

307.7

291

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

32.6

270.1

174

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

202.4

2765

16614

TAB00

NOMESCO Finland

Lumbar puncture

4.5

166.2

428

1011

N91

ICPC

Facial paralysis/bell's palsy

211.3

158.9

164

AA1AD

NOMESCO Finland

CT of head and brain

2.2

143.8

1823

10266

3510A

ICD-9 Finland

Facial nerve disorders, Bell's palsy

+∞

141.2

135

CBK11

NOMESCO Finland

Operation for lagophtalmus with implant

356.2

139.4

140

G50.1

ICD-10 Finland

Atypical facial pain

12.1

137.6

139

118

G50.0

ICD-10 Finland

Trigeminal neuralgia

13.8

136.6

127

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

132.6

656

2381

35008

ICD-8 Finland

Facial paralysis, Alia definita

+∞

131.8

126

G51.9

ICD-10 Finland

Disorder of facial nerve, unspecified

179.7

117.9

123

QAJ10

NOMESCO Finland

Browlift

20.3

104.7

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

35.1

93.5

D33.30

ICD-10 Finland

Acoustic neuroma

10.6

92.0

101

N03AX16

ATC

[U] pregabalin

2.0

91.0

1212

6768

DFF00

NOMESCO Finland

Pure tone audiometry

2.4

90.1

693

3109

UDC00

NOMESCO Finland

Ear microscopy

2.7

88.6

507

1974

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.1

86.3

907

4630

35009

ICD-8 Finland

Facial paralysis, Unspecified

+∞

83.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

7.5

81.3

117

159

CBJ50

NOMESCO Finland

Operation for ptosis of eyebrow

9.5

80.8

103

N03AX12

ATC

[U] gabapentin; oral

2.1

78.5

814

4123

DFF10

NOMESCO Finland

Measurement of acoustic impedance (tympanometry and reflex testing)

17.0

77.2

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

3.7

76.7

255

720

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

74.6

1439

8992

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

71.9

1326

8160

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.3

71.4

601

2791

G54.0

ICD-10 Finland

Brachial plexus disorders

7.6

69.1

131

35000, ,

ICD-8 Finland

+∞

68.9

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.8

68.8

1302

8059

J05AB11

ATC

valaciclovir; oral

2.0

67.8

864

4703

A10AE04

ATC

insulin glargine; parenteral

2.3

67.5

554

2543

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.3

66.2

573

2688

ZZC00

NOMESCO Finland

Graft of fascia

23.7

65.4

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

5.4

64.8

129

244

CBF10

NOMESCO Finland

Shortening of canthal ligaments and tarsal plate for ectropion

18.1

64.6

N02AX02

ATC

tramadol; systemic, rectal

1.6

63.6

2192

15888

R51.80

ICD-10 Finland

Headache

1.9

63.6

868

4828

H49.2

ICD-10 Finland

Sixth [abducent] nerve palsy

6.8

63.5

147

A10BA02

ATC

metformin; oral

1.7

62.8

1501

9889

A02BC02

ATC

pantoprazole; systemic

1.6

62.3

3651

30041

T90

ICPC

Diabetes non-insulin dependent

1.7

60.7

1297

8272

H53.2

ICD-10 Finland

Diplopia

3.3

60.5

237

743

H02.1

ICD-10 Finland

Ectropion of eyelid

6.0

58.7

104

176

TAC00

NOMESCO Finland

Peripheral nerve block

14.0

58.7

R42

ICD-10 Finland

Dizziness and giddiness

1.7

58.6

1246

7926

9560/0-C72.4

ICD-O-3

Schwannoma, NOS, of acoustic nerve

13.3

57.1

H02.4

ICD-10 Finland

Ptosis of eyelid

3.4

56.8

211

640

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.3

56.4

472

2179

A10AC01

ATC

insulin (human); parenteral

2.4

53.1

400

1764

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

51.5

668

3634

R20.2

ICD-10 Finland

Paraesthesia of skin

2.3

51.5

408

1838

CBH25

NOMESCO Finland

Tarsorrhaphy

66.2

51.2

G51.3

ICD-10 Finland

Clonic hemifacial spasm

502.6

50.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

49.7

351

1503

CBN30

NOMESCO Finland

Shortening of canthal ligament

9.2

49.5

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

5.5

48.5

170

A10AB05

ATC

insulin aspart; parenteral

2.2

48.4

412

1912

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

47.9

2446

19004

J01DB01

ATC

cefalexin; oral

1.7

47.6

4389

38762

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.5

47.5

327

1383

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

10.8

44.4

N02BE01

ATC

paracetamol; systemic, rectal

1.8

43.1

4743

43047

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

8.1

42.6

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

41.7

2168

16753

A10BH01

ATC

sitagliptin; oral

2.0

41.2

488

2564

H02.3

ICD-10 Finland

Blepharochalasis

2.2

40.7

355

1662

N06AX21

ATC

duloxetine; oral

1.9

40.7

573

3192

ACC53

NOMESCO Finland

Release of ulnar nerve

66.2

40.1

A10BJ06

ATC

semaglutide; parenteral

2.4

40.0

299

1312

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

40.0

3064

25456

M79.6

ICD-10 Finland

Pain in limb

1.5

39.9

2178

16950

G51.8

ICD-10 Finland

Other disorders of facial nerve

206.5

39.9

QAJ30

NOMESCO Finland

Other facelift

12.3

38.4

A10BB12

ATC

glimepiride; oral

2.2

38.2

332

1552

A10AE05

ATC

insulin detemir; parenteral

2.4

38.1

270

1157

WX110

NOMESCO Finland

Infiltration anesthesia

1.5

37.7

3688

31925

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

37.3

2136

16713

A69.2

ICD-10 Finland

Lyme disease

2.1

37.1

376

1865

G44.2

ICD-10 Finland

Tension-type headache

1.8

37.0

667

4000

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

36.1

900

5885

G51

ICD-10 Finland

Facial nerve disorders

186.2

35.8

N02BF01

ATC

gabapentin; oral

1.9

34.6

474

2611

C03CA01

ATC

furosemide; systemic

1.5

34.5

1395

10157

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

4.1

34.2

228

J01DA01

ATC

[U] cefalexin

1.4

34.1

3070

25919

H02AB04

ATC

methylprednisolone; systemic

1.7

34.0

711

4436

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.4

34.0

250

1089

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

33.8

531

3053

M03BX02

ATC

tizanidine; oral

1.4

33.8

3081

26051

R51.81

ICD-10 Finland

Facial pain NOS

3.2

33.7

133

419

CBF99

NOMESCO Finland

Other operation for ectropion

11.4

33.6

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

33.5

1800

13845

J01AA02

ATC

doxycycline; systemic

1.5

32.8

3976

35286

S18

ICPC

Laceration/cut

1.4

32.8

2294

18481

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

32.7

610

3688

SPAT1262

SPAT

Handing over of treatment supplies

1.6

32.2

817

5350

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

32.2

312

1521

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

32.1

840

5542

J01FF01

ATC

clindamycin; systemic

1.5

32.1

1305

9490

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.6

32.0

777

5035

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

6.2

31.7

E66.01

ICD-10 Finland

Obesity due to excess calories

1.8

31.5

465

2622

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

+∞

31.3

N03AF01

ATC

carbamazepine; oral, rectal

2.4

31.2

225

971

C08CA01

ATC

amlodipine; oral

1.4

31.2

1860

14532

M54.5

ICD-10 Finland

Low back pain

1.4

31.0

1770

13718

N03

ICPC

Pain face

5.0

30.7

134

CBH30

NOMESCO Finland

Tarsorraphy

110.7

30.7

ELB50

NOMESCO Finland

Total parotidectomy

9.1

30.3

PA6AD

NOMESCO Finland

CT of neck arteries

2.4

30.1

218

943

H01

ICPC

Ear pain/earache

1.7

30.0

582

3553

QAJ20

NOMESCO Finland

Subperiosteal facelift

155.9

29.7

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.1

29.7

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.6

29.6

871

5897

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

29.6

466

2679

M03BC01

ATC

orphenadrine (citrate); systemic

1.5

29.6

1042

7342

B02.8

ICD-10 Finland

Zoster with other complications

5.5

29.4

102

CBB10

NOMESCO Finland

Excision of redundant skin of eyelid

3.1

29.2

125

414

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.2

29.1

245

1129

Z3231

NOMESCO Finland

Registered nurse

1.5

29.1

1305

9647

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

2.3

29.1

214

932

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

5.2

29.0

114

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

3.8

29.0

234

G47.3

ICD-10 Finland

Sleep apnoea

1.5

28.9

1112

7972

R03AC02

ATC

salbutamol; inhalant

1.4

28.8

2687

22544

M48.0

ICD-10 Finland

Spinal stenosis

1.8

28.6

499

2957

J05AB01

ATC

aciclovir; systemic

1.5

28.3

1069

7635

DC1AD

NOMESCO Finland

Temporalbone CT

4.1

27.9

191

N06AA09

ATC

amitriptyline; systemic

1.8

27.5

408

2303

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

27.4

435

2505

H02AB07

ATC

prednisone; oral

1.6

27.3

647

4156

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

27.3

1352

10164

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

27.2

283

1417

205

Kela drug reimbursment

Chronic hypertension

1.5

27.0

1176

8625

A02BC03

ATC

lansoprazole; oral

1.4

26.9

1290

9634

AAH50

NOMESCO Finland

Cranial nerve anastomosis

62.3

26.9

A10AE06

ATC

insulin degludec; parenteral

2.5

26.9

177

733

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

26.8

2575

21604

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

26.8

1210

8935

R4120

NOMESCO Finland

Occupational therapy

2.0

26.8

314

1640

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

26.8

1997

16098

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

26.6

1168

8580

R06.0

ICD-10 Finland

Dyspnoea

1.4

26.3

1274

9527

SPAT1263

SPAT

Sampling

1.4

26.1

1957

15771

M01AH05

ATC

etoricoxib; oral

1.4

25.9

3047

26320

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

25.8

1683

13250

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.3

25.8

192

841

R52.9

ICD-10 Finland

Pain, unspecified

1.7

25.6

493

3000

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

25.4

614

3961

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

25.2

1033

7480

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

25.2

294

1534

N02BF02

ATC

pregabalin; oral

1.9

25.0

312

1664

H49.0

ICD-10 Finland

Third [oculomotor] nerve palsy

6.0

24.6

N06AX16

ATC

venlafaxine; oral

1.6

24.6

643

4224

E66.8

ICD-10 Finland

Other obesity

2.0

24.5

269

1373

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

24.4

355

1991

ZXA05

NOMESCO Finland

Left side

1.5

24.0

1063

7799

M01AB05

ATC

diclofenac; systemic, rectal

1.3

23.9

3230

28323

ZXA10

NOMESCO Finland

Bilateral

1.5

23.4

841

5920

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.9

23.3

326

1804

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

23.1

113

404

UJF32

NOMESCO Finland

Coloscopy

1.4

23.0

1196

9029

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

22.9

426

2564

G53.2*D86.8

ICD-10 Finland

Multiple cranial nerve palsies in sarcoidosis

+∞

22.9

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

22.9

386

2261

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.8

22.9

364

2096

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

22.8

1255

9563

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.3

22.8

2689

23042

G35

ICD-10 Finland

Multiple sclerosis

3.2

22.8

295

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

22.6

1819

14733

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

22.6

592

3890

P01AB01

ATC

metronidazole; oral, rectal

1.3

22.2

1865

15195

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.3

22.0

165

725

35399

ICD-8 Finland

Sciatica

+∞

21.9

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

21.8

901

6512

SPAT1301

SPAT

No procedures

1.4

21.8

1400

10936

T89

ICPC

Diabetes insulin dependent

2.2

21.7

185

858

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

21.7

339

1942

A02BC05

ATC

esomeprazole; systemic

1.3

21.5

1889

15472

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.6

21.5

494

3142

R06AE07

ATC

cetirizine; oral

1.3

21.5

2091

17386

SPAT1153

SPAT

Removal of sutures

1.4

21.3

1373

10721

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

26.5

21.3

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

21.2

2415

20518

WX002

NOMESCO Finland

Sedation and analgesia

1.5

21.0

855

6158

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

20.9

867

6268

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

20.8

1015

7558

K02.1

ICD-10 Finland

Caries of dentine

1.3

20.7

2883

25139

L17

ICPC

Foot/toe symptom/complaint

1.4

20.6

1417

11171

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

20.5

510

3306

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

20.5

775

5502

M25.5

ICD-10 Finland

Pain in joint

1.3

20.3

1526

12191

A10BK03

ATC

empagliflozin; oral

1.6

20.2

473

3023

A10AB04

ATC

insulin lispro; parenteral

2.4

20.1

133

553

160

Kela drug reimbursment

exenatide

2.9

20.1

334

D86.0

ICD-10 Finland

Sarcoidosis of lung

3.4

20.1

210

303

Kela drug reimbursment

Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)

3.6

20.0

177

ZXA00

NOMESCO Finland

Right side

1.4

20.0

1113

8474

AAE32

NOMESCO Finland

Translabyrinthine excision acoustic neurinome

57.7

19.9

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

19.8

1118

8529

Z3226

NOMESCO Finland

Physiotherapist

1.5

19.7

805

5799

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.5

19.6

565

3790

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.7

19.5

340

2011

R51

ICD-10 Finland

Headache

1.9

19.4

260

1420

A02BC01

ATC

omeprazole; systemic

1.4

19.4

1216

9435

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

19.4

696

4888

C10AA01

ATC

simvastatin; oral

1.3

19.3

1829

15084

A10BJ02

ATC

liraglutide; parenteral

2.4

19.2

135

577

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

19.2

706

4979

C07.70

ICD-10 Finland

Malignant tumor of the superficial part of the parotid gland

15.6

19.2

ELB60

NOMESCO Finland

Radical parotidectomy sacrificing the facial nerve

+∞

18.8

G50.8

ICD-10 Finland

Other disorders of trigeminal nerve

+∞

18.8

CBH40

NOMESCO Finland

Division of tarsorrhaphy

+∞

18.8

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.9

18.7

254

1393

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.5

18.3

183

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

18.3

299

1735

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

18.3

460

2988

R52.2

ICD-10 Finland

Other chronic pain

2.2

18.2

162

765

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

18.2

1319

10452

J01MA02

ATC

ciprofloxacin; systemic

1.3

18.1

1793

14848

M01AE02

ATC

naproxen; oral, rectal

1.3

18.1

2670

23287

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

18.0

1342

10675

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

4.1

17.9

117

132

Kela drug reimbursment

Sarcoidosis

4.5

17.7

N05CF01

ATC

zopiclone; oral

1.3

17.7

1447

11658

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

17.7

133

586

G51.1

ICD-10 Finland

Geniculate ganglionitis

+∞

17.7

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

17.7

1746

14441

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

17.7

335

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

17.7

2167

18440

R50.9

ICD-10 Finland

Fever, unspecified

1.5

17.4

694

4967

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.7

17.4

344

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

17.3

203

1062

B01AC04

ATC

clopidogrel; oral

1.5

17.3

693

4966

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

17.3

293

1719

N18

ICPC

Paralysis/weakness

2.5

17.2

103

409

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

13.9

17.2

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

17.1

331

2013

ZXD05

NOMESCO Finland

Urgent procedure

1.3

17.1

1368

10981

A10BX04

ATC

[U] exenatide

3.6

17.0

158

G24.5

ICD-10 Finland

Blepharospasm

7.5

17.0

N06AX11

ATC

mirtazapine; oral

1.3

16.9

1565

12812

A10BJ01

ATC

exenatide; parenteral

3.5

16.9

159

M01AC06

ATC

meloxicam; systemic, rectal

1.3

16.8

1589

13048

C07AB07

ATC

bisoprolol; oral

1.3

16.7

2228

19117

S04.5

ICD-10 Finland

Injury of facial nerve

63.5

16.7

EBA00

NOMESCO Finland

Extraction of tooth

1.3

16.6

1695

14055

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

16.6

3542

32182

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

16.6

247

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.4

16.6

115

490

G52.9

ICD-10 Finland

Cranial nerve disorder, unspecified

90.4

16.6

SFA10

NOMESCO Finland

One-surface restoration

1.3

16.5

2636

23108

SPAT1260

SPAT

Consultation of another employee

1.4

16.5

748

5478

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

16.5

813

6043

H62.1*B02.8

ICD-10 Finland

Otitis externa in zoster

16.3

16.5

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

16.5

673

4836

QAJ35

NOMESCO Finland

Other correction of loose or redundant skin of head or neck

170.5

16.5

ZXE00

NOMESCO Finland

One hour or less

1.3

16.4

1759

14672

N06

ICPC

Sensation disturbance other

3.4

16.4

167

R4110

NOMESCO Finland

Physiotherapy

1.3

16.4

1266

10101

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

2.2

16.4

130

587

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.7

16.3

315

1914

G61.0

ICD-10 Finland

Guillain-Barré syndrome

5.4

16.3

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.8

16.3

247

1402

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

16.3

1033

8003

109

Kela drug reimbursment

Multiple sclerosis

3.2

16.3

208

L03

ICPC

Low back symptom/complaint

1.3

16.3

1304

10458

CBB20

NOMESCO Finland

Correction of lax skin of eyelid and resection of herniated fat

3.0

16.2

229

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

16.2

1263

10090

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

16.1

1048

8148

L86

ICPC

Back syndrome with radiating pain

1.8

16.1

262

1519

G57.6

ICD-10 Finland

Lesion of plantar nerve

3.4

16.1

174

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

16.1

363

2297

T82

ICPC

Obesity

1.9

16.0

192

1012

157

Kela drug reimbursment

Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)

3.5

16.0

160

Z71.8

ICD-10 Finland

Other specified counselling

1.3

16.0

1604

13256

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.9

16.0

201

1077

N06AB04

ATC

citalopram; systemic

1.4

15.9

912

6947

R60.0

ICD-10 Finland

Localized oedema

1.5

15.9

554

3860

N03AE01

ATC

clonazepam; systemic

1.8

15.8

244

1394

C10AA05

ATC

atorvastatin; oral

1.3

15.8

1919

16249

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

15.7

846

6380

J01FA06

ATC

roxithromycin; oral

1.3

15.7

1788

15011

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

15.7

536

3719

CBD99

NOMESCO Finland

Other plastic reconstruction of eyelid

15.7

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

15.7

550

3838

L12

ICPC

Hand/finger symptom/complaint

1.4

15.7

731

5380

XA800

NOMESCO Finland

Neuropsychological investigation

1.9

15.7

194

1034

35002

ICD-8 Finland

Facial paralysis, Spasmus facialis

+∞

15.6

119

Kela drug reimbursment

Trigeminal neuralgia or glossofaryngeusneuralgia

+∞

15.6

H92.0

ICD-10 Finland

Otalgia

1.7

15.6

289

1738

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

15.5

1313

10598

A10AB01

ATC

insulin (human); parenteral

2.2

15.5

133

620

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

15.5

599

4260

A02BA02

ATC

ranitidine; systemic

1.4

15.4

799

5985

L28

ICPC

Limited function/disability (L)

1.4

15.4

819

6163

A01

ICPC

Pain general/multiple sites

1.5

15.4

429

2852

H16.0

ICD-10 Finland

Corneal ulcer

1.8

15.3

224

1258

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

15.3

770

5739

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.2

15.3

195

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

15.1

160

808

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.7

15.0

284

1717

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

15.0

3301

29902

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

13.9

15.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.5

15.0

581

4133

J02AC01

ATC

fluconazole; systemic

1.3

15.0

1754

14758

L01

ICPC

Neck symptom/complaint

1.4

14.9

718

5312

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.6

14.9

363

2340

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.1

14.8

148

732

J01CA04

ATC

amoxicillin; systemic

1.3

14.8

4102

38180

DEB00

NOMESCO Finland

Cortical mastoidectomy

31.8

14.8

A04

ICPC

Weakness/tiredness general

1.4

14.8

713

5275

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.4

14.7

597

4281

OAB50, ,

SPAT

1.6

14.7

355

2283

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

14.7

1595

13289

UDQ12

NOMESCO Finland

Flexible laryngoscopy

1.7

14.6

247

1448

A10BB01

ATC

glibenclamide; oral

2.1

14.6

144

709

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

2.4

14.6

400

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

14.5

463

3167

A10BH05

ATC

linagliptin; oral

1.8

14.5

217

1229

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

14.4

168

877

M02AA07

ATC

piroxicam; topical

1.3

14.4

1533

12728

A46

ICD-10 Finland

Erysipelas

1.4

14.4

640

4667

J01MA12

ATC

levofloxacin; systemic

1.4

14.3

797

6037

A10BK01

ATC

dapagliflozin; oral

1.6

14.3

347

2234

L08

ICPC

Shoulder symptom/complaint

1.3

14.3

1011

7944

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

14.3

616

4467

CBW99

NOMESCO Finland

Other operation on eyelid

22.3

14.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.4

14.1

565

4041

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

3.5

14.1

139

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

14.0

814

6205

EB1VA, ,

NOMESCO Finland

1.4

14.0

798

6067

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.6

14.0

345

2231

N02AA05

ATC

oxycodone; systemic

1.4

13.9

763

5767

CBC10

NOMESCO Finland

Removal of foreign body from eyelid

53.5

13.8

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

13.8

490

3425

N07CA01

ATC

betahistine; oral

1.6

13.8

309

1952

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

4.4

13.8

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.9

13.8

183

999

G53.0*B02.21

ICD-10 Finland

Postherpetic geniculate ganglionitis

20.1

13.8

J01DA09

ATC

[U] cefadroxil

1.3

13.7

1148

9229

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.8

13.7

230

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

13.7

380

2523

S29

ICPC

Skin symptom/complaint other

1.3

13.7

919

7162

H57.1

ICD-10 Finland

Ocular pain

1.9

13.6

175

945

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

13.6

1768

15021

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.9

13.6

157

818

N01

ICPC

Headache

1.5

13.6

465

3226

ZZK00

NOMESCO Finland

Graft of nerve

75.3

13.6

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

13.6

4609

43725

DEB30

NOMESCO Finland

Radical mastoidectomy

12.0

13.6

G51.2

ICD-10 Finland

Melkersson syndrome

+∞

13.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

13.5

494

3472

A10BG03

ATC

pioglitazone; oral

2.2

13.5

110

503

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

13.5

1082

8646

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

13.5

1404

11613

M65.3

ICD-10 Finland

Trigger finger

1.9

13.4

165

878

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

13.4

558

4018

C08CA13

ATC

lercanidipine; oral

1.4

13.4

613

4489

C09AA05

ATC

ramipril; oral

1.3

13.4

1058

8436

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.4

13.4

543

3893

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

13.4

403

2724

OAB42, ,

SPAT

1.4

13.4

570

4124

QAJ15

NOMESCO Finland

Browlift using video-endoscope

18.2

13.3

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

2.3

13.3

103

461

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.8

13.3

211

1215

2251A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Cranial nerves

21.2

13.3

R07.3

ICD-10 Finland

Other chest pain

1.5

13.3

448

3098

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.6

13.3

322

2073

D37.00

ICD-10 Finland

Aryepiglottic fold marginal zone

4.7

13.3

R53

ICD-10 Finland

Malaise and fatigue

1.3

13.3

1146

9249

R05

ICPC

Cough

1.3

13.2

1111

8933

R13

ICD-10 Finland

Dysphagia

1.6

13.2

304

1934

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

2.9

13.1

219

F29

ICPC

Eye symptom/complaint other

1.5

13.0

470

3294

G03.9

ICD-10 Finland

Meningitis, unspecified

5.5

13.0

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.5

13.0

317

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

13.0

1229

10031

C09CA01

ATC

losartan; oral

1.3

13.0

1134

9160

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

9.3

12.9

D33.3

ICD-10 Finland

Benign neoplasm: Cranial nerves

19.1

12.9

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

12.9

400

2721

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

3.1

12.9

168

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.1

12.8

122

593

CBK99

NOMESCO Finland

Other operation for retraction of eyelid

50.1

12.8

R52.1

ICD-10 Finland

Chronic intractable pain

3.6

12.8

114

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

12.8

412

2822

R02

ICPC

Shortness of breath/dyspnoea

1.4

12.8

575

4197

XA402

NOMESCO Finland

ENMG

2.5

12.8

308

D10

ICPC

Vomiting

1.7

12.8

249

1518

E0000UV, ,

ATC

1.2

12.8

1924

16594

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

12.7

1320

10902

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

12.7

684

5149

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

12.6

1126

9116

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

12.6

1151

9349

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

12.6

402

2750

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

12.6

264

1641

G56.9

ICD-10 Finland

Mononeuropathy of upper limb, unspecified

5.5

12.6

WX290

NOMESCO Finland

Other blockage of nerve

1.2

12.6

2196

19238

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

12.6

273

1712

CBH10

NOMESCO Finland

Plactic repair of canthus

32.1

12.6

A07AA02

ATC

nystatin; oral

1.7

12.5

232

1397

TQA05

NOMESCO Finland

Puncture of skin of head or neck

17.3

12.5

N03AX09

ATC

lamotrigine; oral

1.8

12.5

190

1082

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.2

12.5

104

481

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

2.8

12.4

220

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

2.8

12.4

209

SFA30

NOMESCO Finland

Three-surface restoration

1.2

12.4

1941

16793

R01AD09

ATC

mometasone; nasal

1.2

12.4

2068

18018

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

3.1

12.4

167

SPAT1310

SPAT

Counselling related to known health issue

1.3

12.3

1357

11277

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

12.3

1142

9290

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

12.3

249

1534

A06AD11

ATC

lactulose; oral

1.4

12.3

592

4374

G51.4

ICD-10 Finland

Facial myokymia

5.8

12.2

WX402

NOMESCO Finland

General anaesthesia

1.3

12.2

998

7982

EL3AE

NOMESCO Finland

Salivary gland ultrasound examination

3.5

12.2

118

R4110, ,

SPAT

1.4

12.2

564

4139

SPAT1216

SPAT

Assessment of functional ability

1.4

12.1

618

4607

XCK00

NOMESCO Finland

Perimetry

1.6

12.1

254

1579

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

12.1

1662

14169

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

2.4

12.1

360

A10AD01

ATC

insulin (human); parenteral

2.6

12.0

270

N06AB06

ATC

sertraline; oral

1.4

12.0

480

3430

WZC00, ,

SPAT

1.4

12.0

650

4894

A10BD07

ATC

metformin and sitagliptin; systemic

1.8

12.0

176

992

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

3.9

12.0

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.5

12.0

423

2954

A10BX07

ATC

[U] liraglutide

2.9

12.0

181

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

11.9

991

7943

C09CA06

ATC

candesartan; oral

1.3

11.9

1070

8664

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

11.9

190

1097

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

11.9

189

1090

R03BA05

ATC

fluticasone; inhalant

1.3

11.9

760

5872

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

3.6

11.9

106

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

11.9

1805

15554

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

11.8

576

4262

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

11.8

1005

8081

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.4

11.8

345

H3600, E103,

ICD-10 Finland

3.1

11.8

156

M01AH01

ATC

celecoxib; oral

1.4

11.7

711

5447

Z2445

NOMESCO Finland

Psychologist

1.8

11.7

157

860

C09AA02

ATC

enalapril; systemic

1.3

11.7

788

6133

N17

ICPC

Vertigo/dizziness

1.4

11.7

556

4098

9560/0-C72.5

ICD-O-3

Schwannoma, NOS, of cranial nerve, NOS

16.4

11.6

R21

ICPC

Throat symptom/complaint

1.3

11.6

894

7088

K04.08

ICD-10 Finland

Other specified pulpit

1.5

11.6

329

2195

M54.2

ICD-10 Finland

Cervicalgia

1.5

11.6

326

2171

AAE34

NOMESCO Finland

Other operations on acoustical nerv

65.1

11.6

D07AC01

ATC

betamethasone; topical

1.2

11.6

1640

14015

E85.80

ICD-10 Finland

Meretoja sick

22.9

11.6

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

11.5

332

2222

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

11.5

195

1145

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

11.5

1231

10180

H46

ICD-10 Finland

Optic neuritis

3.1

11.5

148

M79.1

ICD-10 Finland

Myalgia

1.4

11.5

628

4735

3542A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Lesion of ulnar nerve

+∞

11.5

G52.7

ICD-10 Finland

Disorders of multiple cranial nerves

+∞

11.5

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

11.4

513

3742

8500/3-C07.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of parotid gland

120.3

11.4

H51.0

ICD-10 Finland

Palsy of conjugate gaze

120.3

11.4

CBK10

NOMESCO Finland

Operation for lagophtalmus

120.3

11.4

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

11.4

995

8021

M04AA01

ATC

allopurinol; systemic

1.4

11.4

531

3898

M03BX01

ATC

baclofen; systemic

2.3

11.4

344

A10BJ05

ATC

dulaglutide; parenteral

2.3

11.4

388

K07.60

ICD-10 Finland

Snapping jaw

1.7

11.4

206

1233

M79.7

ICD-10 Finland

Fibromyalgia

1.9

11.3

131

684

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

2.8

11.3

192

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

11.3

469

3374

J01EA01

ATC

trimethoprim; systemic

1.3

11.3

1103

9020

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

11.3

156

864

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.0

11.3

117

589

Z2221

NOMESCO Finland

Medical doctor

1.3

11.2

1213

10042

J01FA09

ATC

clarithromycin; systemic

1.3

11.2

1352

11337

N06AX12

ATC

bupropion; oral

1.6

11.2

295

1937

R74

ICPC

Upper respiratory infection acute

1.2

11.1

1452

12283

P03

ICPC

Feeling depressed

1.5

11.1

404

2835

H93.1

ICD-10 Finland

Tinnitus

1.5

11.1

300

1980

ACC19

NOMESCO Finland

Transcision of peripheral nerve: other or unspecified

12.7

11.1

K08.80

ICD-10 Finland

Toothache NOS

1.5

11.1

375

2597

G56.3

ICD-10 Finland

Lesion of radial nerve

8.0

11.0

Z01.2

ICD-10 Finland

Dental examination

1.2

11.0

2144

18909

C03DA01

ATC

spironolactone; oral

1.4

11.0

509

3735

ZXD20

NOMESCO Finland

Day surgery

1.4

10.9

504

3697

H71

ICD-10 Finland

Cholesteatoma of middle ear

2.9

10.9

180

UKC02

NOMESCO Finland

Cystoscopy

1.4

10.9

645

4925

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

10.8

225

1396

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

2.4

10.8

321

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.5

10.8

399

2808

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

3.0

10.8

159

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

2.3

10.8

359

NDM40

NOMESCO Finland

Discission of sheath of tendon of wrist or hand

2.2

10.8

391

N29

ICPC

Neurological sympt/complt other

2.2

10.8

391

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

3.3

10.8

123

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

10.8

107

530

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

10.8

777

6104

G56.4

ICD-10 Finland

Causalgia

28.1

10.7

G50.9

ICD-10 Finland

Disorder of trigeminal nerve, unspecified

17.8

10.7

C01DA14

ATC

isosorbide mononitrate; oral

1.4

10.7

582

4383

SPAT1097

SPAT

Recording of ECG

1.4

10.7

575

4322

SPAT1211

SPAT

Application of soft bandage

1.5

10.7

341

2334

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

10.7

285

1878

G53.0

ICD-10 Finland

Postzoster neuralgia

3.8

10.6

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

10.6

863

6890

M01AH03

ATC

valdecoxib; oral

1.6

10.6

231

1452

A10AB06

ATC

insulin glulisine; parenteral

2.9

10.6

172

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.9

10.6

129

687

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.3

10.6

1174

9744

C02AC05

ATC

moxonidine; oral

1.7

10.5

182

1076

B01AB05

ATC

enoxaparin; parenteral

1.2

10.5

1356

11448

J20

ICD-10 Finland

Acute bronchitis

1.4

10.5

439

3165

SPAT1254

SPAT

Administration of medicine

1.4

10.4

589

4461

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

10.4

3194

29374

QAZ00

NOMESCO Finland

Botulin injections for hyperhidrosis of head and neck

110.2

10.4

35701

ICD-8 Finland

Other diseases of peripheral nerves except autonomic, Nervi mediani

+∞

10.4

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.6

10.4

230

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

10.4

147

820

C03AA03

ATC

hydrochlorothiazide; oral

1.5

10.4

351

2429

L03AB07

ATC

interferon beta-1a; parenteral

3.4

10.4

106

N93

ICPC

Carpal tunnel syndrome

3.7

10.4

Z00.0

ICD-10 Finland

General medical examination

1.3

10.4

812

6447

J01FA10

ATC

azithromycin; systemic

1.2

10.4

2638

23832

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

2.2

10.3

379

A10AA01, ,

ATC

2.1

10.3

418

B02.29

ICD-10 Finland

Herpes zoster polyneuropathy

32.6

10.3

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.1

10.3

425

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.2

10.3

393

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

10.2

231

1464

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

10.2

133

723

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

10.2

255

1656

G57.3

ICD-10 Finland

Lesion of lateral popliteal nerve

3.4

10.1

103

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

10.1

546

4106

R03DC03

ATC

montelukast; oral

1.3

10.1

680

5289

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

10.1

142

792

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.5

10.1

371

2612

R33

ICD-10 Finland

Retention of urine

1.5

10.1

313

2131

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

10.1

1726

14999

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

10.1

527

3945

DBD20

NOMESCO Finland

Plastic repair of external auditory canal

4.3

10.0

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.8

10.0

144

808

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

10.0

507

3774

A10BG02

ATC

rosiglitazone; oral

2.5

10.0

241

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

9.9

243

1570

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

9.9

556

4206

SGA01

NOMESCO Finland

Emergency treatment

1.3

9.9

684

5336

C10AX09

ATC

ezetimibe; oral

1.3

9.9

705

5525

H65.3

ICD-10 Finland

Chronic mucoid otitis media

2.2

9.9

373

C08CA02

ATC

felodipine; oral

1.4

9.9

372

2629

N05CF02

ATC

zolpidem; oral

1.3

9.9

721

5669

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

2.4

9.9

291

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

9.9

159

923

D33.39

ICD-10 Finland

Benign tumor of the cranial nerves UNS

12.2

9.8

G81.9

ICD-10 Finland

Hemiplegia, unspecified

2.8

9.8

168

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.3

9.8

323

A29

ICPC

General symptom/complaint other

1.3

9.8

577

4397

D33.37

ICD-10 Finland

Another benign tumor of the cranial nerves

26.0

9.8

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

9.8

461

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

9.8

A10AA02, ,

ATC

1.9

9.8

110

571

E66.9

ICD-10 Finland

Obesity, unspecified

1.8

9.7

145

823

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.5

9.7

296

2007

L04AX03

ATC

methotrexate; systemic

1.4

9.7

393

2815

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

9.7

547

4142

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.2

9.7

1353

11503

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

9.7

103

524

H60.3

ICD-10 Finland

Other infective otitis externa

2.0

9.7

104

531

D07AB02

ATC

hydrocortisone butyrate; topical

1.2

9.7

1281

10829

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

9.6

400

2879

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

9.6

342

2392

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

8.4

9.5

G04CA02

ATC

tamsulosin; oral

1.3

9.5

920

7499

ZX120

NOMESCO Finland

Intravenous

1.4

9.5

384

2749

C09BA02

ATC

enalapril and diuretics; systemic

1.5

9.5

306

2098

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

10.0

9.5

K11.2

ICD-10 Finland

Sialoadenitis

1.8

9.5

140

792

L15

ICPC

Knee symptom/complaint

1.3

9.5

1057

8763

S22.3

ICD-10 Finland

Fracture of rib

1.5

9.4

292

1986

KMAK, ,

NOMESCO Finland

1.2

9.4

2325

20879

R55

ICD-10 Finland

Syncope and collapse

1.4

9.4

448

3301

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

9.4

437

3208

3518X

ICD-9 Finland

Facial nerve disorders, Other facial nerve disorders

+∞

9.4

3519X

ICD-9 Finland

Facial nerve disorders, Facial nerve disorder, unspecified

+∞

9.4

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

9.4

155

907

R01AD08

ATC

fluticasone; nasal

1.2

9.3

1239

10470

ZZF00

NOMESCO Finland

Graft of adipose tissue

2.9

9.3

151

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.9

9.3

120

652

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

3.2

9.3

109

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.9

9.3

104

539

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.4

9.3

503

3785

K30

ICD-10 Finland

Functional dyspepsia

1.4

9.2

472

3518

Z2446

NOMESCO Finland

Social worker

1.5

9.2

259

1726

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

9.2

1091

9103

A87.9

ICD-10 Finland

Viral meningitis, unspecified

3.5

9.2

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

9.1

300

2066

F45.8

ICD-10 Finland

Other somatoform disorders

1.5

9.1

264

1771

M01AH02

ATC

rofecoxib; oral

1.4

9.1

464

3457

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

9.1

518

3927

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.6

9.1

191

1192

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

9.0

289

1980

M54.3

ICD-10 Finland

Sciatica

1.6

9.0

226

1470

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

2.7

9.0

165

M01AX17

ATC

nimesulide; oral

1.3

9.0

934

7675

WX704

NOMESCO Finland

Intubation

1.5

9.0

313

2181

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

9.0

216

1392

SPAT1255

SPAT

Intravenous administration of medicine

1.5

8.9

265

1787

A03FA01

ATC

metoclopramide; systemic, rectal

1.3

8.9

940

7735

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

2.2

8.9

343

H19.8*E85.80

ICD-10 Finland

Reticular keratitis in Meretoja's patients

24.0

8.9

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

24.0

8.9

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.3

8.9

A11

ICPC

Chest pain NOS

1.4

8.9

348

2480

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

1.8

8.8

116

634

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

2.2

8.8

306

A10AD04

ATC

insulin lispro; parenteral

4.5

8.8

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

8.8

160

961

TDA90

NOMESCO Finland

Removal wax from ear

2.4

8.8

256

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

8.8

496

3756

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

8.8

448

3339

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.4

8.8

453

3383

R03BA02

ATC

budesonide; inhalant

1.3

8.7

730

5839

H49.1

ICD-10 Finland

Fourth [trochlear] nerve palsy

3.3

8.7

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

8.7

249

1667

R1430, ,

SPAT

2.2

8.7

308

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

8.7

450

3364

H15.0

ICD-10 Finland

Scleritis

4.2

8.6

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.4

8.6

384

2798

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

2.4

8.6

240

A03

ICPC

Fever

1.3

8.6

718

5741

SPAT1050

SPAT

Extensive neurological examination

2.1

8.6

408

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.4

8.6

333

2367

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

8.6

509

3882

J01DA06

ATC

[U] cefuroxime

1.3

8.6

573

4447

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

8.6

1443

12480

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

8.5

402

2958

E66

ICD-10 Finland

Obesity

1.5

8.5

221

1449

SPAT1360

SPAT

Extensive global examination

1.5

8.5

262

1782

TCC10

NOMESCO Finland

Probing of lacrimal canaliculus/duct

3.5

8.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

8.5

382

2788

C07.71

ICD-10 Finland

Malignant tumor in the deep part of the parotid gland

27.5

8.5

S21

ICPC

Skin texture symptom/complaint

1.3

8.5

640

5053

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

8.5

152

911

A02BA04

ATC

nizatidine; systemic

1.5

8.4

281

1941

H36.01

ICD-10 Finland

Diabetic maculopathy

2.4

8.4

218

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.6

8.4

215

1404

H62.1*B00.19

ICD-10 Finland

Otitis externa in herpesviral [herpes simplex] infection

90.2

8.4

N05AH04

ATC

quetiapine; oral

1.3

8.4

724

5814

SFA20

NOMESCO Finland

Two-surface restoration

1.2

8.4

2728

24999

PA6BG

NOMESCO Finland

MRI examination of neck vasculature with high intensity magnet

3.1

8.4

111

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

8.4

189

N06AA10

ATC

nortriptyline; systemic

2.1

8.4

346

H29

ICPC

Ear symptom/complaint other

1.3

8.4

507

3881

SPAT1229

SPAT

Assessment of need for aid

1.5

8.3

274

1888

4182

FHL

Surgery on the facial nerve

+∞

8.3

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

8.3

272

1872

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.8

8.3

118

661

P06

ICPC

Sleep disturbance

1.3

8.3

536

4139

N03AX11

ATC

topiramate; oral

2.0

8.3

462

R39.1

ICD-10 Finland

Other difficulties with micturition

1.8

8.3

125

713

XKC03

NOMESCO Finland

Water cystometry

1.8

8.3

114

633

R06.2

ICD-10 Finland

Wheezing

1.6

8.3

174

1086

J01MA14

ATC

moxifloxacin; systemic

1.4

8.3

356

2579

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

1.9

8.3

102

547

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.3

8.3

493

3765

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.2

8.2

1071

9016

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.2

289

2018

I50.9

ICD-10 Finland

Heart failure, unspecified

1.3

8.2

533

4120

S01BC03

ATC

diclofenac; ophthalmic

1.9

8.2

499

Z50.1

ICD-10 Finland

Other physical therapy

1.6

8.2

193

1238

R01AD58

ATC

fluticasone, combinations; nasal

1.2

8.2

1061

8928

H01.0

ICD-10 Finland

Blepharitis

1.5

8.2

283

1970

S06.0

ICD-10 Finland

Concussion

1.4

8.2

430

3221

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

2.7

8.2

151

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

8.2

1405

12166

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

8.2

588

4612

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

8.2

181

1145

K04.0

ICD-10 Finland

Pulpitis

1.4

8.1

367

2680

R05FB02

ATC

cough suppressants and expectorants; systemic

1.2

8.1

1568

13721

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.4

8.1

350

2536

R11

ICD-10 Finland

Nausea and vomiting

1.4

8.1

353

2562

G37.9

ICD-10 Finland

Demyelinating disease of central nervous system, unspecified

3.1

8.1

108

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.6

8.1

204

1329

A10AD05

ATC

insulin aspart; parenteral

2.2

8.1

298

L04AA06

ATC

mycophenolic acid; systemic

2.0

8.1

418

XKD00

NOMESCO Finland

Uroflowmetry

1.3

8.1

601

4733

J45.8

ICD-10 Finland

Mixed asthma

1.8

8.1

118

667

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

8.1

118

667

CBH99

NOMESCO Finland

Other operation on canthus

33.4

8.1

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.4

8.1

420

3141

H03AA01

ATC

levothyroxine sodium; systemic

1.2

8.1

969

8089

DFF59

NOMESCO Finland

Other assessment of balance

2.5

8.0

199

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.4

8.0

368

2695

K08.3

ICD-10 Finland

Retained dental root

1.4

8.0

316

2254

H60.1

ICD-10 Finland

Cellulitis of external ear

2.3

8.0

242

L02

ICPC

Back symptom/complaint

1.4

8.0

417

3119

S02.11

ICD-10 Finland

Fracture of base of skull, open

4.1

8.0

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

8.0

437

3295

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

8.0

827

6790

ZX114

NOMESCO Finland

Intramuscular

2.3

7.9

243

N05CD07

ATC

temazepam; oral

1.4

7.9

430

3235

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.8

7.9

142

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.6

7.9

190

1224

P76

ICPC

Depressive disorder

1.5

7.9

258

1775

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

7.9

498

D01AC02

ATC

miconazole; topical

1.5

7.9

283

1983

SPAT1312

SPAT

General health counselling

1.2

7.9

1327

11456

WX320

NOMESCO Finland

Spinalanesthesy

1.2

7.9

1023

8604

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

1.8

7.9

123

709

D05BB02

ATC

acitretin; oral

1.9

7.8

500

E000001, ,

ATC

1.3

7.8

803

6584

R06AX22

ATC

ebastine; oral

1.3

7.8

694

5592

W19

ICD-10 Finland

Unspecified fall

1.4

7.8

394

2932

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.5

7.8

208

1373

CBF20

NOMESCO Finland

Resection of part of tarsus for ectropion

8.4

7.8

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.8

1872

16689

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

2.5

7.8

190

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.3

7.8

513

3974

N06AB03

ATC

fluoxetine; oral

1.3

7.8

478

3667

N03AF02

ATC

oxcarbazepine; oral

1.8

7.8

116

661

R96

ICPC

Asthma

1.4

7.8

387

2875

SPAT1283

SPAT

Restricted health certificate

1.3

7.7

655

5248

C07AG02

ATC

carvedilol; oral

1.5

7.7

220

1474

ELB40

NOMESCO Finland

Partial parotidectomy

2.3

7.7

234

A01AB09

ATC

miconazole; local oral

1.4

7.7

318

2290

K10.3

ICD-10 Finland

Alveolitis of jaws

1.6

7.7

184

1187

N05BA04

ATC

oxazepam; oral

1.2

7.6

1116

9501

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

2.4

7.6

204

H65.0

ICD-10 Finland

Acute serous otitis media

2.1

7.6

352

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

7.6

171

1085

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

2.7

7.6

151

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.5

7.6

243

1666

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.4

7.6

296

2109

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.2

7.6

274

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.6

7.6

169

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

7.6

182

1175

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.1

7.5

334

X58

ICD-10 Finland

Exposure to other specified factors

1.3

7.5

593

4707

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

2.4

7.5

218

CKC12

NOMESCO Finland

Photocoagulation of retina

1.6

7.5

162

1019

A98

ICPC

Health maint/preventive medicine

1.4

7.5

5115

49930

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.8

7.5

109

617

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

7.5

1283

11094

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

1.7

7.4

125

737

8070/3-C07.9

ICD-O-3

Squamous cell carcinoma, NOS, of parotid gland

80.2

7.4

A99

ICPC

Disease/condition unspecnature/site

1.3

7.4

422

3201

N30.0

ICD-10 Finland

Acute cystitis

1.3

7.4

716

5828

WX720

NOMESCO Finland

Own respiration

1.6

7.4

180

1165

R01AD11

ATC

triamcinolone; nasal

1.4

7.4

329

2400

D07AA02

ATC

hydrocortisone; topical

1.3

7.4

546

4298

H02.0

ICD-10 Finland

Entropion and trichiasis of eyelid

1.9

7.4

447

M54

ICD-10 Finland

Dorsalgia

1.3

7.4

508

3961

R03BA08

ATC

ciclesonide; inhalant

1.4

7.4

333

2435

D06

ICPC

Abdominal pain localized other

1.4

7.3

360

2668

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

7.3

572

4534

L13

ICPC

Hip symptom/complaint

1.3

7.3

770

6329

AAH60

NOMESCO Finland

Microvascular decompression of cranial nerve

+∞

7.3

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

7.3

1034

8774

EAB20

NOMESCO Finland

Plastic repair of lip

10.9

7.3

G97.1

ICD-10 Finland

Other reaction to spinal and lumbar puncture

6.8

7.3

H10

ICD-10 Finland

Conjunctivitis

1.4

7.3

302

2176

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

7.3

157

988

H60

ICD-10 Finland

Otitis externa

1.5

7.3

215

1452

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.0

7.3

352

C07AA05

ATC

propranolol; systemic

1.2

7.3

823

6820

164

Kela drug reimbursment

Fingolimod

4.1

7.3

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.4

7.2

197

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

7.2

471

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.7

7.2

123

728

R03AK08

ATC

formoterol and beclometasone; inhalant

1.6

7.2

172

1108

N06AX26

ATC

vortioxetine; oral

1.4

7.2

300

2162

H25.8

ICD-10 Finland

Other senile cataract

1.3

7.2

415

3155

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.4

7.2

288

2063

L60.0

ICD-10 Finland

Ingrowing nail

1.6

7.2

180

1174

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

7.2

242

1679

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

7.1

738

6052

GAE40

NOMESCO Finland

Operation on rib and soft tissues for thoracic outlet syndrome

30.0

7.1

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.4

7.1

261

1838

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

7.1

251

1755

S02.10

ICD-10 Finland

Fracture of base of skull, closed

3.5

7.1

R4190

NOMESCO Finland

Nutritional therapy

1.6

7.1

154

970

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.6

7.1

155

978

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

7.1

457

3528

H70.0

ICD-10 Finland

Acute mastoiditis

7.9

7.1

GBB00

NOMESCO Finland

Tracheostomy

2.4

7.1

199

LCA06

NOMESCO Finland

Biopsy of endometrium

1.3

7.1

435

3337

C10AB05

ATC

fenofibrate; oral

2.0

7.1

349

162

Kela drug reimbursment

liraglutide

2.5

7.1

163

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.7

7.1

111

643

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.7

7.0

140

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.3

7.0

530

4182

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.2

7.0

779

6439

G46.3*I67.9

ICD-10 Finland

Brain stem stroke syndrome (I60-I67+)

3.6

7.0

B02AA02

ATC

tranexamic acid; systemic

1.3

7.0

574

4579

F02.89*G35

ICD-10 Finland

Dementia in multiple sclerosis

7.0

XCD10

NOMESCO Finland

Electrophysiological examination of eye

1.9

7.0

477

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.0

7.0

358

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.5

6.9

198

1329

PA6AG

NOMESCO Finland

Limited MRI examination of neck vasculature with high intensity magnet

3.0

6.9

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.4

6.9

334

2470

D02

ICPC

Abdominal pain epigastric

1.5

6.9

241

1683

AA4CG

NOMESCO Finland

Extensive MRI examination of sella turcica with high intensity magnet

2.4

6.9

177

L04AX01

ATC

azathioprine; systemic

1.6

6.9

162

1041

J02AC02

ATC

itraconazole; systemic

1.3

6.9

706

5784

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.2

6.9

927

7821

S97

ICPC

Chronic ulcer skin

1.5

6.9

229

1585

N99

ICPC

Neurological disease other

2.2

6.9

240

F03

ICPC

Eye discharge

1.4

6.8

271

1937

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

2.1

6.8

273

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.3

6.8

393

2986

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

6.8

278

1997

N06AB10

ATC

escitalopram; oral

1.2

6.8

833

6956

SAA04

NOMESCO Finland

Special examination of mouth

1.5

6.8

186

1236

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

6.8

267

1905

R4120, ,

SPAT

2.2

6.8

241

G63.0*B02.29

ICD-10 Finland

Postherpetic polyneuropathy

10.9

6.8

G56.1

ICD-10 Finland

Other lesions of median nerve

10.9

6.8

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.3

6.8

393

2989

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

2.3

6.8

197

R03AC03

ATC

terbutaline; inhalant

1.3

6.8

542

4309

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

6.8

433

3341

C07

ICD-10 Finland

Malignant neoplasm of parotid gland

40.1

6.8

R01AD05

ATC

budesonide; nasal

1.4

6.8

290

2103

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

2.0

6.7

328

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

6.7

194

1304

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.7

500

3937

H22.1*D86.8

ICD-10 Finland

Iridocyclitis in sarcoidosis

16.7

6.7

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.2

6.7

710

5836

N05BA01

ATC

diazepam; systemic, rectal

1.3

6.7

495

3896

L16

ICPC

Ankle symptom/complaint

1.3

6.7

472

3692

ZXE30

NOMESCO Finland

More than five and less than seven hours

1.5

6.7

179

1185

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

2.6

6.7

144

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.3

6.7

536

4264

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

6.7

162

1050

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.1

6.7

276

P01

ICPC

Feeling anxious/nervous/tense

1.3

6.6

478

3749

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.6

6.6

163

1059

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

6.6

219

1514

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.5

6.6

171

1123

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.5

6.6

184

1228

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.6

228

1589

S10

ICPC

Boil/carbuncle

1.5

6.6

230

1606

NG1DA

NOMESCO Finland

X-ray of knees

2.0

6.6

317

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.2

6.6

890

7510

WX892

NOMESCO Finland

Monitored bed care

1.4

6.6

288

2096

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.6

6.6

126

771

R31

ICD-10 Finland

Unspecified haematuria

1.3

6.6

392

2995

CD2S4

NOMESCO Finland

Photography of eye

2.9

6.6

100

UDM02

NOMESCO Finland

Sinoscopy

1.8

6.6

465

A10BH02

ATC

vildagliptin; oral

1.9

6.6

380

T83

ICPC

Overweight

1.8

6.5

487

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.4

6.5

279

2021

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

6.5

1059

9093

B02.20

ICD-10 Finland

Herpes zoster trigeminal neuralgia

8.7

6.5

G53.0*B02.20

ICD-10 Finland

Trigeminal neuralgia after shingles

8.7

6.5

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.1

6.5

278

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.5

6.5

205

1403

N92

ICPC

Trigeminal neuralgia

10.0

6.5

C07AB02

ATC

metoprolol; systemic

1.2

6.5

762

6334

A12BA01

ATC

potassium chloride; oral

1.6

6.5

147

937

C09DA01

ATC

losartan and diuretics; oral

1.3

6.5

414

3193

R4130

NOMESCO Finland

Speech therapy

1.7

6.5

105

614

R75

ICPC

Sinusitis acute/chronic

1.5

6.5

176

1169

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.2

6.5

866

7298

N02AC04

ATC

dextropropoxyphene; oral

1.7

6.5

117

705

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.0

6.5

347

A10BX02

ATC

repaglinide; oral

2.3

6.5

214

N06AB05

ATC

paroxetine; oral

1.5

6.5

220

1530

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.6

6.5

150

962

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

6.4

168

1106

3AX01, ,

NOMESCO Finland

5.3

6.4

H04.2

ICD-10 Finland

Epiphora

2.6

6.4

135

H3601, E103,

ICD-10 Finland

2.7

6.4

118

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

6.4

881

7444

QDB10, ,

SPAT

1.8

6.4

549

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

2.9

6.4

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

7.4

6.4

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

2.0

6.4

328

R20.1

ICD-10 Finland

Hypoaesthesia of skin

2.8

6.4

113

R5130, ,

SPAT

3.7

6.4

SBA00

NOMESCO Finland

Microbiological examinations

1.8

6.3

544

R06AX27

ATC

desloratadine; oral

1.2

6.3

1209

10536

H02AB09

ATC

hydrocortisone; systemic

1.8

6.3

515

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.4

6.3

263

1899

AA1BD

NOMESCO Finland

Extensive CT of head and brain

1.8

6.3

545

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.3

373

2848

H60.8

ICD-10 Finland

Other otitis externa

1.6

6.3

128

796

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

6.3

165

1089

Q51.0

ICD-10 Finland

Agenesis and aplasia of uterus

18.0

6.3

G04BD12

ATC

mirabegron; oral

1.3

6.3

466

3672

G52.8

ICD-10 Finland

Disorders of other specified cranial nerves

+∞

6.2

CBH05

NOMESCO Finland

Canthopexy

+∞

6.2

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.3

6.2

527

4219

JN4BD

NOMESCO Finland

Extensive body CT

1.3

6.2

398

3072

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

6.2

226

1592

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.5

6.2

160

1051

R06.5

ICD-10 Finland

Mouth breathing

1.3

6.2

350

2652

K11.70

ICD-10 Finland

Hypoptyalism

3.0

6.2

JN4AD

NOMESCO Finland

Body CT examination

1.3

6.2

462

3641

SPAT1081

SPAT

Cardiorespiratory global assessment

1.5

6.2

186

1263

Y6099

ICD-8 Finland

Prenatal care and observation

1.6

6.2

143

917

DFF15

NOMESCO Finland

Speech audiometry

1.5

6.2

183

1239

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

6.2

247

1771

L04AA27

ATC

[U] fingolimod

5.3

6.1

G63.2

ICD-10 Finland

Diabetic polyneuropathy

5.3

6.1

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

6.1

952

8139

C10AB02

ATC

bezafibrate; oral

2.3

6.1

200

R04.2

ICD-10 Finland

Haemoptysis

1.6

6.1

125

778

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

1.7

6.1

109

655

DEB10

NOMESCO Finland

Attico-antro-mastoidectomy

7.7

6.1

F43.1

ICD-10 Finland

Post-traumatic stress disorder

1.8

6.1

535

H65.2

ICD-10 Finland

Chronic serous otitis media

2.1

6.1

259

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

2.7

6.1

110

PA7BD

NOMESCO Finland

CT angiography of neck and brain

2.0

6.1

320

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.4

6.1

213

1490

G83.4

ICD-10 Finland

Cauda equina syndrome

3.8

6.1

M75.3

ICD-10 Finland

Calcific tendinitis of shoulder

1.9

6.1

391

M01AX05

ATC

glucosamine; oral

1.2

6.0

689

5710

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

6.0

808

6808

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.6

6.0

124

773

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.5

6.0

151

986

CBN99

NOMESCO Finland

Other operation on eyelid for malposition

2.9

6.0

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.3

6.0

348

2647

M75.8

ICD-10 Finland

Other shoulder lesions

1.6

6.0

144

931

G04BD08

ATC

solifenacin; oral

1.4

6.0

238

1703

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1428

2833

6.46

307.65

1.4

1.3

57.20

49.91

au/ml

0.50

196

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1518

3078

6.44

307.65

2.6

2.4

20.11

20.90

au/ml

0.12

129

360

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

274

402

7.12

178.30

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

420

1021

4.37

157.00

1.4

1.2

3.80

3.73

mmol/l

0.70

401

969

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

446

1166

4.08

151.19

1.4

1.3

584.51

539.53

mg/l

0.83

432

1107

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

394

1030

4.04

133.24

1.5

1.4

434.15

1207.05

e6/l

1.20

308

799

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

157

169

9.53

131.91

1.1

778.77

274.58

ng/l

0.68

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

387

1012

4.04

130.78

1.5

1.4

42.70

21.92

e6/l

0.75

283

726

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

157

242

6.65

97.24

1.1

1.14

1.17

u/l

0.12

110

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2158

14424

1.82

93.75

2.3

2.2

205.35

215.59

u/l

0.20

2066

13642

(3013826) Glucose [Moles/volume] in Serum or Plasma

3559

27743

1.81

90.07

5.7

5.0

6.94

6.64

mmol/l

11.06

3401

26221

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

170

327

5.33

83.77

1.1

343.51

266.60

mg/l

1.44

148

288

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

172

338

5.22

82.75

1.2

1.1

49.21

41.94

mg/l

0.72

148

282

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1257

7344

1.92

81.63

2.2

2.1

29.20

29.67

2.35

1231

7135

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

144

247

5.96

80.21

1.1

—

(3032080) INR in Blood by Coagulation assay

2863

21550

1.69

76.15

13.1

15.0

1.20

1.26

inr

8.73

2409

17957

(3023410) Appearance of Cerebral spinal fluid

196

473

4.26

73.40

1.7

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

153

305

5.13

72.41

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

132

243

5.54

68.24

1.3

1.2

0.58

0.59

ratio

0.12

137

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

123

217

5.78

66.53

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

152

6.82

65.20

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

151

359

4.30

57.65

1.2

1.3

2.05

2.11

mmol/l

0.20

145

331

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2327

17569

1.56

54.12

4.3

3.6

39.39

50.45

ng/l

0.78

1652

12016

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

167

461

3.70

51.89

1.3

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

2156

16189

1.55

50.24

3.8

3.4

7.67

7.66

mmol/l

0.03

1820

13710

(3020682) Albumin/Creatinine [Ratio] in Urine

2053

15277

1.55

49.68

4.7

4.1

9.16

8.83

mg/mmol

0.11

1345

9563

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2945

23708

1.52

49.31

8.3

7.3

1.21

mmol/l

0.23

2568

20481

(3012516) Albumin [Mass/volume] in Urine

2017

15016

1.54

48.36

3.9

3.4

49.80

48.99

mg/l

0.06

1358

9604

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3050

24860

1.51

47.23

7.2

6.8

11.09

11.66

umol/l

1.67

2937

23712

(3024561) Albumin [Mass/volume] in Serum or Plasma

2672

21210

1.51

46.87

5.4

5.2

35.79

35.65

g/l

0.59

2507

19878

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

3994

34683

1.56

44.40

5.1

4.2

12.32

11.94

mm/h

0.97

3792

32464

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5007

46218

1.96

42.82

20.2

15.5

22.58

24.60

mg/l

4.34

4354

37897

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2643

21213

1.47

42.13

7.4

6.7

1.21

mmol/l

0.14

2464

19616

(3023368) Bacteria identified in Blood by Culture

1762

13063

1.51

41.46

4.7

4.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

643

3697

1.84

41.34

2.9

2.8

9.94

10.63

g/l

4.33

593

3412

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4119

36223

1.55

41.23

9.5

8.3

78.45

79.14

u/l

0.51

3924

34399

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

227

4.42

39.65

1.3

1.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

137

5.54

39.16

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

3249

27407

1.46

38.35

10.9

10.0

4.24

4.12

e9/l

1.88

2829

23645

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1943

14876

1.47

38.25

2.9

2.6

62.65

61.60

u/l

0.08

1807

13783

(3019069) Monocytes/Leukocytes in Blood

2755

22548

1.45

38.12

8.0

6.7

8.81

8.86

0.44

2603

21157

(3006504) Eosinophils/Leukocytes in Blood

2746

22503

1.44

37.48

7.9

6.6

2.79

2.84

0.68

2596

21096

(3013115) Eosinophils [#/volume] in Blood

3025

25239

1.44

37.43

7.8

6.6

0.20

0.19

e9/l

0.60

2642

21941

(3019198) Lymphocytes [#/volume] in Blood

3000

24994

1.44

37.40

7.7

6.4

1.89

1.90

e9/l

0.12

2635

21905

(3022096) Basophils/Leukocytes in Blood

2745

22501

1.44

37.36

8.0

6.7

0.66

0.68

1.25

2585

21082

(3006315) Basophils [#/volume] in Blood

2950

24510

1.44

37.27

7.7

6.4

0.04

e9/l

0.02

2526

20948

(3023103) Potassium [Moles/volume] in Serum or Plasma

5062

47224

1.93

37.04

23.5

18.3

3.96

3.97

mmol/l

1.18

4982

46214

(3002030) Lymphocytes/Leukocytes in Blood

2806

23117

1.44

37.02

7.8

6.6

27.33

27.66

0.87

2674

21904

(3001604) Monocytes [#/volume] in Blood

2941

24440

1.44

37.00

7.7

6.4

0.60

0.59

e9/l

1.23

2523

20886

(3019550) Sodium [Moles/volume] in Serum or Plasma

5051

47121

1.91

36.47

23.4

18.1

139.62

139.68

mmol/l

1.02

4976

46195

(3007853) Bacteria identified in Skin by Aerobe culture

847

5459

1.65

35.94

1.8

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

5.81

35.77

1.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

389

2017

2.00

33.97

2.7

2.0

40.22

39.92

u/l

0.10

360

1798

(3018010) Neutrophils/Leukocytes in Blood

2734

22666

1.41

33.37

7.6

6.5

57.89

57.40

1.41

2631

21658

(3031040) Bacteria [#/volume] in Urine by Automated count

3548

30913

1.42

31.76

5.6

4.6

541.84

1879.60

e6/l

1.85

405

(3026008) Bacteria identified in Urine by Culture

1829

14249

1.43

31.16

3.6

3.2

—

(3018418) pH of Serum or Plasma

1828

14302

1.42

30.16

4.6

4.3

7.40

0.30

1347

10152

(3036481) Cortisol [Moles/volume] in Serum or Plasma

685

4432

1.62

28.14

2.5

2.4

351.44

382.96

nmol/l

4.17

639

4126

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2506

20862

1.37

27.81

2.2

2.1

95.65

95.83

pmol/l

0.06

1331

11134

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4664

43145

1.54

27.80

6.0

5.3

1.88

1.90

mu/l

0.60

4359

40048

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

2121

17217

1.38

27.42

3.9

3.4

—

1.54

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4701

43606

1.55

27.20

7.8

6.0

41.05

38.81

mmol/mol

34.63

4424

40904

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

212

3.81

26.49

1.2

1.3

63.06

72.12

0.40

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2620

22096

1.36

26.13

3.1

2.8

—

estimate

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1998

16167

1.37

25.93

3.7

3.3

33.47

35.84

u/l

0.59

1879

15283

(3033658) Prothrombin time (PT) actual/Normal

1597

12514

1.39

25.04

4.6

4.1

91.74

89.52

3.20

1570

12253

(3002582) Erythrocytes [#/volume] in Urine

1944

15727

1.37

25.01

4.0

3.4

131.38

83.47

e6/l

0.34

1492

11874

(3020564) Creatinine [Moles/volume] in Serum or Plasma

5178

49384

1.87

24.93

25.7

20.0

78.50

77.23

umol/l

1.67

5131

48790

(3026493) Urate [Moles/volume] in Serum or Plasma

1585

12443

1.39

24.45

2.9

2.7

345.11

342.49

umol/l

0.45

1409

11052

(3000850) Epithelial cells [#/volume] in Urine

1396

10746

1.40

24.17

3.0

2.7

5.57

5.70

e6/l

0.15

1271

9765

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

4785

44788

1.54

24.08

19.1

15.2

81.69

ml/min/173m2

0.01

4437

41343

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1079

7952

1.44

23.80

2.1

1.9

—

(3042936) Bacteria identified in Isolate by Culture

928

6671

1.47

23.27

2.1

2.0

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4007

36436

1.37

22.55

4.9

4.4

14.73

14.75

pmol/l

0.21

3719

33543

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1579

12524

1.37

22.46

2.6

2.3

2.94

2.79

mg/l

1.64

1358

10844

(3030467) Casts [#/volume] in Urine by Automated count

1706

13696

1.36

22.45

3.8

3.3

0.40

0.43

e6/l

0.17

1259

9924

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1203

9139

1.41

22.20

4.1

3.8

470.93

526.91

ng/l

0.12

891

7076

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1708

13738

1.35

22.13

3.3

3.2

1314.84

1391.03

ng/l

0.34

1444

11839

(3026782) Osmolality of Urine

1212

9226

1.40

22.08

3.3

2.9

520.56

531.96

mosm/kgh2o

1.04

1061

8093

(3009261) Glucose [Presence] in Urine by Test strip

2936

25578

1.32

21.69

4.7

3.8

0.02

0.08

estimate

0.41

617

5106

(3021589) Normoblasts [#/volume] in Blood

2534

21632

1.32

21.64

13.5

11.4

0.00

e9/l

0.16

2082

17570

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.24

21.43

1.1

—

(3037522) Nuclear Ab [Titer] in Serum

904

6563

1.45

21.36

1.4

449.36

538.22

titre

0.94

188

1407

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

243

1259

1.97

21.23

2.7

2.1

10.91

11.90

mg/l

0.86

225

1170

(3021601) Nitrite [Presence] in Urine by Test strip

2887

25148

1.31

21.07

4.6

3.8

0.00

estimate

0.27

637

5291

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5128

49015

1.71

21.07

14.6

11.8

28.12

26.38

u/l

2.49

4998

47602

(3035350) Ketones [Presence] in Urine by Test strip

2912

25405

1.31

20.97

4.6

3.8

7.87

5.59

estimate

0.20

668

5413

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2653

22906

1.31

20.38

3.5

3.1

119.13

125.96

ug/l

0.89

2459

21447

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1338

10470

1.37

20.37

2.0

1.8

1.28

1.26

mg/l

0.03

1038

8072

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4732

44495

1.46

20.14

5.7

5.0

6.15

5.89

mmol/l

21.86

4372

41006

(3021960) Folate [Moles/volume] in Serum or Plasma

1651

13375

1.34

19.92

1.7

19.41

20.17

nmol/l

1.26

1391

11395

(3044640) Blood type and Crossmatch panel - Blood

1889

15612

1.32

19.79

2.9

2.4

—

(3018095) Leukocytes [#/volume] in Urine

2144

18044

1.31

19.65

4.7

3.9

88.29

100.63

e6/l

0.27

1539

12549

(3003458) Phosphate [Moles/volume] in Serum or Plasma

863

6307

1.44

19.53

6.7

6.1

1.05

1.04

mmol/l

0.45

796

5887

(3015736) pH of Urine

2369

20220

1.30

19.51

4.0

3.4

6.21

6.22

0.07

1334

11244

(3019309) Folate [Moles/volume] in Red Blood Cells

1018

7663

1.40

19.50

1.8

1.7

1154.49

1168.57

nmol/l

0.19

790

5809

(36304419) Bacteria [Presence] in Urine

1606

13016

1.33

19.16

3.7

3.2

2262.33

301.22

estimate

0.39

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1235

9633

1.36

18.98

1.9

1.7

66765156.15

31496201.93

pmol/l

0.56

1020

8036

(3013512) EKG study

1906

15856

1.31

18.79

4.1

3.5

0.67

0.70

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3576

32329

1.31

18.59

3.8

3.2

47.97

47.55

u/l

0.12

3393

30420

(3012544) pH of Venous blood

691

4887

1.47

18.52

4.2

3.9

7.38

0.08

410

2759

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

813

5933

1.43

18.46

2.0

1.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

768

5565

1.44

18.10

2.0

1.8

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.59

17.94

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

677

4817

1.46

17.54

4.2

3.9

5.82

5.79

kpa

0.25

658

4689

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

277

2.92

17.43

1.1

4.45

13.11

nmol/l

0.77

(3002032) Base excess in Venous blood by calculation

661

4688

1.47

17.40

4.2

3.9

1.64

1.77

mmol/l

0.41

584

4103

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1003

7674

1.38

17.19

2.8

2.6

2.38

2.31

g/l

3.44

921

7122

(3022948) Iron [Moles/volume] in Serum or Plasma

1064

8230

1.36

17.01

2.9

2.6

12.77

13.07

umol/l

0.66

981

7704

(3015377) Calcium [Moles/volume] in Serum or Plasma

1955

16502

1.29

16.73

3.5

3.7

2.35

mmol/l

0.05

1773

15020

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1464

11898

1.31

16.66

2.7

2.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2496

21745

1.27

16.46

2.7

2.4

75.40

77.30

nmol/l

2.94

2281

19804

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

929

7070

1.38

16.38

2.9

2.6

21.78

22.74

1.36

855

6592

(3007461) Platelets [#/volume] in Blood

5237

50663

1.75

16.36

30.5

23.6

252.13

251.40

e9/l

0.35

5153

49624

(3035941) MCH [Entitic mass]

5237

50671

1.74

16.24

30.3

23.5

30.18

30.33

7.67

5200

50132

(3024731) MCV [Entitic mean volume] in Red Blood Cells

5237

50671

1.74

16.24

30.3

23.5

90.72

91.08

7.52

5199

50132

(3026361) Erythrocytes [#/volume] in Blood

5237

50677

1.74

16.15

30.4

23.6

4.51

4.49

e12/l

1.38

5144

49489

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

5237

50678

1.74

16.14

31.0

24.1

41.26

40.91

0.15

5199

50115

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

127

3.80

16.05

1.1

—

(3010813) Leukocytes [#/volume] in Blood

5237

50684

1.74

16.05

30.5

23.6

6.99

6.72

e9/l

10.08

5141

49486

(3000963) Hemoglobin [Mass/volume] in Blood

5237

50686

1.74

16.02

30.7

23.8

135.10

135.34

g/l

0.56

5201

50160

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

123

3.85

15.96

1.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1081

8461

1.35

15.87

1.4

1.3

37.09

30.74

iu/ml

0.48

344

2505

(3019977) pH of Arterial blood

742

5479

1.41

15.60

8.1

8.2

7.42

0.08

424

2944

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1003

7787

1.35

15.49

1.3

8.84

11.63

u/ml

0.74

379

3092

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1091

8582

1.34

15.44

1.6

1.5

—

(3024354) Oxygen [Partial pressure] in Venous blood

569

4015

1.47

15.30

3.7

3.2

4.61

4.57

kpa

0.20

551

3896

(3028679) Herpes simplex virus Ab [Presence] in Serum

245

2.88

15.01

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

317

1973

1.64

15.00

1.5

1.6

37.60

13.78

iu/ml

—

(3027801) Oxygen [Partial pressure] in Arterial blood

738

5481

1.40

14.97

8.2

12.40

12.51

kpa

0.24

710

5264

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

738

5482

1.40

14.95

8.2

5.05

5.08

kpa

0.46

710

5261

(3025159) Blasts/Leukocytes in Blood

582

4146

1.45

14.88

4.7

4.9

0.24

0.30

0.10

151

1047

(3017181) Myelocytes/Leukocytes in Blood

599

4293

1.44

14.83

4.5

4.7

0.90

0.95

0.18

182

1294

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

4.06

14.68

1.3

1.4

—

(3003396) Base excess in Arterial blood by calculation

729

5432

1.39

14.47

8.1

8.2

0.94

0.89

mmol/l

0.12

584

4456

(3002179) Metamyelocytes/Leukocytes in Blood

574

4102

1.45

14.42

4.2

4.5

0.63

0.72

0.52

172

1222

(3028026) IgM [Mass/volume] in Serum or Plasma

430

2902

1.52

14.38

2.3

1.9

1.43

1.34

g/l

0.25

403

2673

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

5.20

14.36

1.2

78.40

58.59

1.41

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

496

3452

1.48

14.28

1.8

1.7

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

144

3.42

14.08

1.1

1.2

15.08

19.00

0.15

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1023

8075

1.33

13.98

3.6

3.5

0.82

mmol/l

0.29

971

7620

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

3.66

13.96

1.1

—

(3021440) Promyelocytes/Leukocytes in Blood

571

4104

1.44

13.89

4.5

4.7

0.09

0.12

0.41

156

1109

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

131

3.53

13.87

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2182

18999

1.25

13.51

4.6

3.7

0.01

0.26

estimate

0.91

529

4363

(3027945) Reticulocytes/Erythrocytes in Blood

724

5452

1.38

13.43

2.6

2.7

1.92

1.81

1.63

629

4857

(3029937) Albumin [Presence] in Urine by Test strip

1636

13793

1.27

13.39

4.8

4.0

0.00

estimate

2.65

593

4879

(3020630) Protein [Mass/volume] in Serum or Plasma

551

3963

1.43

13.34

2.6

2.7

66.19

66.39

g/l

0.26

507

3650

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

630

4643

1.40

13.29

2.3

0.22

0.21

g/l

2.55

590

4336

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

270

1665

1.65

13.27

1.3

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

318

2044

1.59

13.21

5.9

5.2

1.62

0.01

304

1927

(40768804) Tissue Pathology biopsy report

2227

19475

1.24

13.14

2.2

2.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

317

2045

1.58

12.97

3.5

3.3

25.43

25.25

mmol/l

0.42

306

1976

(40768797) Stomach Pathology biopsy report

837

6487

1.34

12.87

1.2

1.3

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.97

12.58

1.1

5.89

18.45

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4860

46592

1.38

12.48

6.3

5.6

2.65

2.73

mmol/l

7.49

4554

43547

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1062

8572

1.30

12.15

3.4

2.9

1.03

1.14

e6/l

0.42

556

4475

(3023520) Reticulocytes [#/volume] in Blood

567

4167

1.40

12.12

2.6

2.7

73.94

70.35

e9/l

1.37

428

2997

(3004119) Hemoglobin [Mass/volume] in Venous blood

423

2947

1.47

12.10

3.6

3.2

128.53

129.39

g/l

0.31

409

2867

(3002173) Hemoglobin [Mass/volume] in Arterial blood

607

4515

1.39

12.08

9.1

9.2

120.45

121.29

g/l

0.48

597

4409

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

107

507

2.13

12.07

1.6

—

(3016502) Oxygen saturation in Arterial blood

647

4867

1.37

12.02

8.6

95.71

95.63

0.10

628

4694

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

526

3826

1.41

11.93

2.3

7.50

8.01

ug/l

0.16

456

3373

(3000494) Fungus identified in Specimen by Culture

753

5809

1.34

11.88

1.6

1.5

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

290

1871

1.58

11.87

6.2

5.5

0.88

0.87

0.10

279

1763

(3011412) CD3 cells [#/volume] in Blood

453

2.18

11.77

2.8

2.4

1257.21

1151.15

e6/l

0.56

399

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

985

7903

1.30

11.76

3.6

3.1

3.51

2.59

e6/l

1.28

473

3782

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

227

2.71

11.75

1.0

1.1

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

732

5640

1.34

11.64

4.7

257.68

242.63

u/l

1.12

689

5364

(3008152) Bicarbonate [Moles/volume] in Arterial blood

402

2802

1.47

11.47

8.6

7.0

24.43

24.44

mmol/l

0.02

385

2677

(1175426) CD3 cells/Lymphocytes in Blood

375

2.29

11.43

2.4

2.1

72.14

72.76

0.12

360

(3020779) Urea [Moles/volume] in Serum or Plasma

589

4403

1.38

11.36

8.2

7.6

9.78

9.70

mmol/l

0.08

560

4221

(3017143) Hepatitis C virus Ab [Presence] in Serum

728

5633

1.34

11.23

1.8

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4791

45952

1.34

11.22

5.6

4.9

4.53

4.65

mmol/l

12.23

4513

43104

(3041096) Erythrocytes [Presence] in Urine by Automated

1597

13674

1.24

10.93

4.0

3.2

0.07

0.06

estimate

0.14

526

4166

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1148

9487

1.27

10.73

2.8

3.1

2.45

mmol/l

0.01

1006

8518

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

363

2.25

10.53

2.4

2.1

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

474

2.09

10.53

1.2

—

41.50

—

(3014051) Protein [Presence] in Urine by Test strip

1596

13717

1.23

10.44

3.3

2.9

0.00

0.04

2.13

300

(3010838) Calcium [Moles/time] in 24 hour Urine

145

805

1.82

10.43

2.0

4.79

4.95

mmol/24h

0.25

134

714

(3019150) Specific gravity of Urine by Refractometry

1289

10840

1.25

10.29

4.9

3.9

1.02

1.16

kg/l

0.50

877

7117

(3036489) Thrombin time

279

1852

1.53

10.11

2.6

2.1

21.34

21.05

0.27

252

1648

(3015235) Bicarbonate [Moles/volume] in Capillary blood

245

1581

1.58

10.06

3.4

3.1

24.62

24.91

mmol/l

0.62

240

1555

(40758558) Short blood count panel - Blood

1672

14486

1.22

10.04

7.2

6.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4754

45681

1.31

9.94

5.5

4.9

1.39

1.46

mmol/l

30.85

4449

42590

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4558

43564

1.27

9.93

4.7

4.2

1.40

1.28

mmol/l

19.54

4227

40225

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

216

1357

1.62

9.93

1.4

1.7

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

159

921

1.75

9.93

1.3

1.9

0.93

0.86

nmol/l

0.45

124

791

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

626

4822

1.34

9.91

3.4

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

223

1413

1.60

9.90

1.6

1.7

0.25

0.24

g/l

1.98

209

1343

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

297

2.34

9.88

3.2

2.4

541.92

530.09

e6/l

0.06

236

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

423

3064

1.41

9.82

4.2

3.6

5.14

5.15

kpa

0.10

398

2927

(46235355) HIV 1 and 2 tests - Meaningful Use set

1087

9009

1.26

9.81

2.0

1.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

471

2.03

9.59

1.6

1.7

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

228

1465

1.58

9.56

1.6

1.7

1.24

1.19

g/l

1.80

218

1394

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

4.01

9.49

1.1

—

(3009343) pH of Capillary blood

411

2982

1.41

9.45

4.2

3.6

7.41

7.42

0.59

347

2451

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

4130

39099

1.23

9.45

24.2

19.2

13.71

13.60

5.79

4093

38561

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.95

9.30

2.3

2.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

1283

10887

1.23

9.29

5.4

4.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

364

2593

1.43

9.28

4.1

3.5

1.74

1.86

mmol/l

0.31

267

1922

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2219

19862

1.20

9.27

2.0

1.9

1.48

1.35

mmol/l

4.89

1850

16820

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

190

1182

1.63

9.12

1.4

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

500

3777

1.36

8.99

3.8

4.0

1.23

mmol/l

0.17

446

3266

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

415

5574

0.72

8.99

1.9

2.0

3.64

3.49

ratio

1.44

315

4284

(3007164) IgA [Mass/volume] in Serum or Plasma

1151

9686

1.24

8.97

1.7

1.5

2.37

2.44

g/l

0.64

748

6046

(3014148) Varicella zoster virus Ab [Titer] in Serum

121

667

1.83

8.96

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

198

1250

1.61

8.96

1.7

1.6

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

567

4368

1.33

8.95

7.4

8.1

1.33

mmol/l

0.00

553

4278

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

235

1545

1.54

8.93

2.8

2.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

299

2.26

8.87

3.3

2.6

210.83

225.68

e6/l

0.23

251

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

157

944

1.68

8.62

1.5

1.4

—

(3004809) Band form neutrophils/Leukocytes in Blood

130

743

1.77

8.56

4.0

3.8

1.15

1.66

1.40

115

662

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

140

818

1.73

8.54

1.4

1.3

168.89

447.95

titre

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

231

1529

1.53

8.53

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

177

1102

1.63

8.50

3.4

3.0

1.55

mmol/l

0.04

171

1068

(4146454) Self-monitoring of blood glucose

453

1.98

8.41

2.8

2.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

201

1297

1.57

8.32

1.8

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

251

1701

1.50

8.30

2.2

2.3

505.57

653.77

ug/l

0.28

238

1616

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

483

1.94

8.30

1.4

1.3

1.43

1.52

nmol/l

0.41

436

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

175

1098

1.61

8.16

1.6

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.91

8.14

1.1

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

494

1.92

8.11

1.2

1.1

1.29

2.54

iu/ml

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

467

3554

1.34

8.00

4.3

3.9

91.93

90.16

ng/l

0.14

393

3046

(3032352) Blasts [#/volume] in Cerebral spinal fluid

4.13

7.98

3.0

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3186

29644

1.18

7.96

3.1

3.0

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

470

1.93

7.92

1.4

1.5

69.07

58.70

1.70

299

(3030981) Hyaline casts [#/volume] in Urine by Automated count

496

3821

1.33

7.82

2.9

2.4

0.30

0.42

e6/l

0.93

482

3656

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

149

2.70

7.81

1.4

2.1

575.00

26265.38

u/ml

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

702

5665

1.27

7.81

2.8

2.9

7.12

8.45

umol/l

1.06

619

4978

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

129

758

1.72

7.75

1.5

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

177

1130

1.59

7.70

2.3

2.2

130.01

128.98

g/l

0.20

140

866

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

366

2700

1.38

7.66

10.0

10.9

16.09

15.98

0.32

355

2604

(3017354) Segmented neutrophils/Leukocytes in Blood

476

1.91

7.64

3.6

3.8

58.81

57.58

0.19

406

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

333

2419

1.40

7.64

1.5

—

(3038515) Glucose [Moles/volume] in Venous blood

149

914

1.65

7.63

3.6

3.1

7.97

7.31

mmol/l

1.72

143

888

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.97

7.60

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

276

1941

1.44

7.59

1.7

1.8

7.28

6.91

iu/ml

0.09

453

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

165

1040

1.60

7.58

5.7

6.0

530.03

2024.08

iu/ml

0.47

144

(3027923) C peptide [Moles/volume] in Serum or Plasma

236

2.30

7.56

1.7

1.4

1.28

1.21

nmol/l

0.16

173

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

158

2.61

7.51

1.4

1.2

0.29

0.30

g/l

0.52

126

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

227

1540

1.49

7.50

1.7

1.5

1.11

0.29

iu/ml

0.50

295

(3000060) B lymphocytes [#/volume] in Blood

136

2.73

7.42

3.0

2.0

0.10

0.21

e9/l

1.70

(3000991) Gas panel - Venous blood

534

4198

1.30

7.28

9.0

9.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

257

1798

1.45

7.27

1.2

0.38

1.31

u/ml

1.94

143

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

1917

1.44

7.23

2.3

4.24

4.22

g/l

0.19

244

1751

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

1918

1.43

7.21

2.3

7.25

7.39

g/l

0.69

245

1752

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

301

4106

0.72

7.17

1.6

1.7

3.52

3.49

mmol/l

0.14

201

2828

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

147

914

1.63

7.16

1.6

1.4

—

(3006245) CD3-CD19+ cells/cells in Blood

186

2.43

7.15

3.0

2.2

14.18

10.06

0.84

175

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1265

10971

1.20

7.08

1.4

1.3

1.66

1.92

u/ml

0.24

335

3000

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

913

7671

1.23

7.07

1.8

1.7

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

206

1390

1.50

7.01

1.4

11.53

9.90

u/l

0.91

159

1132

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

256

1804

1.44

6.99

2.3

2.70

2.94

g/l

4.13

230

1639

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

211

1432

1.49

6.98

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

407

3098

1.34

6.98

1.4

1.3

169.25

213.33

u/ml

0.90

377

2878

(3021788) Differential panel - Synovial fluid

135

827

1.65

6.98

1.4

1.5

—

1.00

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

383

2891

1.35

6.95

4.5

4.1

24.12

24.18

mmol/l

0.16

378

2862

(3021879) Hepatitis B virus core Ab [Presence] in Serum

494

3868

1.30

6.94

1.6

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

181

1191

1.54

6.93

1.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

268

1908

1.43

6.92

2.3

1.9

5.03

2.12

ug/l

0.83

235

1695

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

269

1918

1.42

6.89

2.3

3.66

3.73

g/l

0.31

243

1753

(3024980) IgG subclass 4 [Mass/volume] in Serum

136

838

1.64

6.88

1.5

1.6

0.61

0.77

g/l

1.33

105

649

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

204

1382

1.49

6.82

1.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

183

1214

1.52

6.76

1.1

1.2

3.95

3.88

0.04

172

(3040151) Glucose [Moles/volume] in Capillary blood

511

1.81

6.75

5.1

4.3

7.71

7.00

mmol/l

0.89

438

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

702

5762

1.25

6.73

1.8

1.45

0.01

614

5107

(3011397) Hemoglobin [Presence] in Urine by Test strip

1328

11619

1.19

6.68

4.3

3.7

0.08

0.16

0.42

128

(3047181) Lactate [Moles/volume] in Blood

196

1324

1.50

6.65

7.2

6.3

1.32

mmol/l

0.05

175

1163

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

382

2904

1.34

6.62

9.0

10.3

24.21

24.24

mmol/l

0.08

373

2845

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

243

1717

1.43

6.56

2.4

2.3

3806.99

5853.94

u/l

0.67

688

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

6.17

6.45

1.1

2.30

7.68

u/l

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

235

1657

1.44

6.42

2.2

2.3

9.89

10.38

g/l

1.01

204

1480

(3017732) Neutrophils [#/volume] in Blood

727

6022

1.24

6.41

3.4

3.2

4.76

4.55

e9/l

0.22

615

5234

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

149

959

1.57

6.33

2.5

2.3

94.17

101.68

ug/min

0.11

578

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.58

6.30

1.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

153

993

1.56

6.27

1.7

1.4

31.30

18.65

u/ml

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

396

1.88

6.14

1.4

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

396

1.88

6.14

1.4

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

396

1.88

6.14

1.4

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

226

2.18

6.11

1.5

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

226

2.18

6.11

1.5

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

226

2.18

6.11

1.5

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

226

2.18

6.11

1.5

1.8

—

(3035933) Granulocytes/Leukocytes in Blood

159

1051

1.53

6.02

3.5

3.4

59.24

58.08

0.63

159

1051

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

121

752

1.62

5.97

1.1

92.90

14453.54

iu/ml

0.53

162

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

394

3055

1.31

5.97

3.0

3.6

4.44

4.50

pmol/l

0.42

349

2750

(3025941) Bacteria identified in Stool by Culture

333

2521

1.34

5.96

1.3

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

151

990

1.54

5.94

1.7

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

635

5232

1.24

5.87

7.8

6.6

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

557

1.72

5.85

1.3

1.2

—

(4035726) Immunohistochemistry procedure

531

4293

1.26

5.80

1.5

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

508

1.74

5.74

1.4

1.3

0.34

0.42

g/l

2.00

361

(3028192) IgG subclass 2 [Mass/volume] in Serum

508

1.74

5.74

1.4

1.3

2.33

2.99

g/l

3.93

361

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.46

5.72

1.2

1.1

—

(3003181) Sodium [Moles/volume] in Urine

137

887

1.56

5.71

1.5

1.4

62.68

62.44

mmol/l

0.02

113

714

(3027135) IgG subclass 1 [Mass/volume] in Serum

509

1.74

5.70

1.4

1.3

5.80

6.84

g/l

2.06

362

(3048689) Calprotectin [Mass/mass] in Stool

735

6175

1.22

5.64

2.5

153.75

134.14

ug/g

0.63

592

4949

(3045414) Leukocytes [Presence] in Urine

557

4546

1.25

5.61

2.2

2.1

0.04

0.01

estimate

0.37

108

967

(40761536) Microorganisms panel - Urine sediment

485

3899

1.27

5.56

4.8

3.9

—

(3022145) Colonoscopy Study observation

657

5466

1.23

5.55

1.4

—

(3039000) Anion gap in Blood by calculation

139

910

1.54

5.53

8.6

7.6

11.47

11.40

mmol/l

0.10

129

812

(3018572) Chloride [Moles/volume] in Blood

139

911

1.54

5.50

8.6

7.6

104.97

105.24

mmol/l

0.30

129

813

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

229

1657

1.40

5.46

1.9

1.8

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

246

1802

1.38

5.46

2.1

1.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

196

1380

1.44

5.45

1.4

1.3

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

403

3174

1.29

5.45

9.9

10.2

1.35

1.30

0.32

398

3153

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

120

763

1.59

5.43

1.2

4.37

3.89

u/ml

0.10

269

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

16.03

5.41

1.1

1.2

1.56

1.40

mg/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

314

1.92

5.38

1.1

1.2

—

(3019225) pH of Specimen

534

4361

1.25

5.35

4.8

4.2

7.37

7.35

0.93

402

3078

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

273

1.99

5.34

3.3

2.6

41.39

41.59

0.02

144

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

449

3595

1.27

5.33

3.2

3.0

176.33

200.63

ng/l

0.73

402

3275

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.40

5.30

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.40

5.30

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

153

1033

1.49

5.29

1.3

1.2

21.14

94.05

u/ml

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

246

1817

1.37

5.20

1.6

11.35

15.74

u/ml

0.93

456

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

211

1523

1.40

5.13

3.3

2.6

3.54

3.58

g/l

0.14

201

1454

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

108

680

1.60

5.11

1.5

1.3

28.08

28.59

u/l

0.05

561

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

196

1399

1.42

5.08

1.3

9.30

40.52

u/ml

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

193

1376

1.42

5.04

2.3

0.00

g/l

-0.00

160

1212

(3008295) Osmolality of Serum or Plasma

529

1.67

5.01

1.4

277.88

278.26

mosm/kgh2o

0.05

412

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

132

877

1.52

4.95

1.9

1.7

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

124

813

1.54

4.94

3.2

2.9

53577.40

1383.12

u/ml

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

135

902

1.51

4.93

1.7

1.5

155.85

150.74

au/ml

0.19

269

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

143

967

1.49

4.93

1.3

1.2

241.85

270.19

u/ml

0.61

592

(4062490) Immunoglobulin typing, IgG

501

1.69

4.93

1.4

1.3

—

(3037756) Immunofixation for Serum or Plasma

142

959

1.49

4.93

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

195

1399

1.41

4.92

1.4

296.11

278.44

ug/g

0.64

104

805

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

578

4810

1.23

4.87

2.7

2.5

118.81

39.28

u/l

0.47

491

4085

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1430

1.40

4.82

2.3

0.04

0.03

g/l

0.24

174

1289

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

228

1689

1.37

4.76

2.6

2.4

0.55

0.97

g/l

1.32

193

1448

(3008757) Leukocyte morphology finding [Identifier] in Blood

431

1.73

4.75

4.5

4.2

—

(3016038) Potassium [Moles/volume] in Urine

314

1.86

4.74

1.2

35.82

35.10

mmol/l

0.09

284

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

258

1.95

4.71

1.1

1442.10

1502.95

miu/ml

0.15

258

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

546

1.64

4.71

2.3

1.8

13328.00

937.60

titre

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

229

1702

1.36

4.69

2.0

1.7

287.39

296.88

mu/l

0.17

206

1547

(3033705) Calcium.ionized [Moles/volume] in Venous blood

479

1.68

4.65

2.5

2.3

1.20

mmol/l

0.03

473

(3018405) Lactate [Moles/volume] in Arterial blood

204

1493

1.38

4.61

4.9

3.8

1.36

1.38

mmol/l

0.12

198

1467

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

124

828

1.51

4.57

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

14.02

4.57

1.9

1.0

—

(3016879) Cocaine [Presence] in Urine

229

1715

1.35

4.48

2.0

2.1

—

(21494814) CD8 cells/Lymphocytes in Specimen

201

2.05

4.47

1.9

2.2

33.90

30.56

0.62

201

(3006922) Hepatitis E virus Ab [Presence] in Serum

394

1.74

4.46

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

299

1.85

4.46

1.9

1.7

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

468

3848

1.24

4.44

3.2

2.7

63.79

67.22

ml/min/173m2

1.06

221

1599

(3002079) Sodium [Moles/time] in 24 hour Urine

209

2.02

4.40

1.1

1.3

168.71

160.64

mmol/24h

0.21

209

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

367

2943

1.26

4.34

1.8

1.7

—

(3028707) Methadone [Presence] in Urine by Screen method

116

773

1.51

4.34

2.1

2.8

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

120

806

1.50

4.33

1.1

24.38

15.68

au/ml

0.56

213

(3052851) Hemolysis interference index of Serum or Plasma

182

1322

1.39

4.32

3.0

3.2

1.67

1.99

index

0.41

696

(4015189) Microbial culture of sputum

2.53

4.29

2.3

2.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

137

947

1.46

4.28

1.4

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

744

1.52

4.26

1.3

3.38

4.47

u/ml

0.60

333

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

276

1.86

4.21

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

493

1.63

4.20

2.5

2.2

4.01

4.07

mmol/l

0.67

487

(3035285) Chloride [Moles/volume] in Venous blood

493

1.63

4.20

2.5

2.2

105.55

105.38

mmol/l

0.13

487

(3016650) Hepatitis A virus Ab [Presence] in Serum

119

804

1.49

4.18

1.2

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

121

2.32

4.16

2.3

2.9

28.43

29.24

umol/l

0.13

(3034891) Synovial lining cells/cells in Synovial fluid

200

2.01

4.16

1.3

1.5

4.78

4.28

—

(3000475) Leukocytes [#/volume] in Synovial fluid

155

1103

1.42

4.16

1.7

1.5

13912.75

14319.92

e6/l

0.05

114

750

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

263

1.87

4.15

1.1

1.07

1.06

ratio

0.23

210

(3007566) Smooth muscle Ab [Titer] in Serum

188

1383

1.37

4.15

1.2

136.92

112.90

titre

0.19

124

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

136

947

1.45

4.11

1.4

1.3

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

622

5302

1.20

4.10

2.3

2.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

396

3229

1.24

4.07

1.2

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

149

1058

1.42

4.06

1.9

1.6

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

306

2422

1.28

4.05

1.4

22.47

27.48

iu/l

2.04

252

2065

(3022313) Gas panel - Capillary blood

268

2087

1.30

4.03

4.5

3.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

169

2.08

4.00

1.7

1.9

—

(44790047) Parainfluenza type 1 nucleic acid detection

627

1.54

3.97

1.7

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

627

1.54

3.97

1.7

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

627

1.54

3.97

1.7

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

627

1.54

3.97

1.7

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

628

1.54

3.95

1.4

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

283

1.81

3.92

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

209

1579

1.34

3.91

2.9

3.2

0.39

0.33

iu/ml

1.33

111

856

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

150

1075

1.41

3.89

1.2

1.3

1.71

3.80

u/ml

0.48

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

567

1.56

3.88

1.3

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

167

1220

1.38

3.87

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

207

1564

1.34

3.87

3.1

2.2

92.28

92.29

0.00

200

1515

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

209

1582

1.33

3.86

3.5

90.98

51.80

mg/l

0.30

172

1331

(3034860) Kappa light chains.free [Mass/volume] in Serum

209

1584

1.33

3.83

3.5

41.96

87.15

mg/l

0.71

172

1333

(3028433) Virus identified in Specimen by Culture

152

2.11

3.83

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

569

1.56

3.82

1.3

1.4

—

(3011288) Drugs identified in Urine by Screen method Nominal

174

1285

1.37

3.78

3.1

2.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

531

1.57

3.78

2.8

2.1

28.24

21.65

mg/l

0.47

185

(4268621) Lupus anticoagulant assay

547

1.56

3.77

2.1

2.3

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.73

3.75

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

223

1.89

3.71

24.4

27.7

108.06

114.36

ug/l

0.34

181

(3027944) Amphetamines [Presence] in Urine

236

1830

1.30

3.69

2.0

2.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

173

1285

1.36

3.64

2.4

2.3

0.00

g/l

-0.00

160

1212

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

576

1.54

3.64

1.3

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

169

2.02

3.63

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

169

2.02

3.63

1.7

1.9

—

(3023183) Ammonium ion [Moles/volume] in Plasma

142

1022

1.40

3.62

3.1

2.8

35.98

34.95

umol/l

0.13

125

927

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

145

1049

1.39

3.59

1.2

46.95

38.35

u/ml

0.19

(3028300) Cannabinoids [Presence] in Urine

239

1864

1.30

3.59

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.72

3.58

1.1

—

(3049717) Cytology report of Urine Cyto stain

220

1698

1.31

3.57

2.4

2.6

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

367

1.67

3.57

1.5

23.04

30.07

0.77

217

(3027008) Opiates [Presence] in Urine

238

1857

1.29

3.56

2.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.57

3.54

1.2

1.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

119

834

1.44

3.53

1.6

1.3

—

(1616796) Gas panel - Central venous blood

146

1062

1.39

3.51

3.7

3.9

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

107

736

1.46

3.50

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

213

1642

1.31

3.49

4.5

3.7

24.72

24.89

mmol/l

0.39

198

1497

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.62

3.49

1.2

1.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

175

1313

1.34

3.47

1.3

1.93

5.56

u/ml

0.78

119

(3003327) Ova and parasites identified in Stool by Light microscopy

217

1681

1.30

3.44

1.6

1.7

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

4066

39412

1.12

3.44

25.3

19.8

332.14

332.35

g/l

0.72

4048

39179

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

488

1.57

3.44

1.4

1.3

—

(4195642) Thrombophilia screening test

103

706

1.47

3.44

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

144

1049

1.38

3.44

4.4

4.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

548

4696

1.19

3.43

1.9

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

395

1.63

3.41

1.1

1.2

102.86

107.88

pmol/l

0.39

395

(3020876) Protein [Mass/time] in 24 hour Urine

569

1.52

3.41

2.4

1.15

1.33

g/24h

0.31

336

(3025468) Yersinia sp identified in Specimen by Organism specific culture

546

1.53

3.38

1.3

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

174

1310

1.34

3.38

1.3

2.74

7.77

u/ml

2.29

194

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

5.72

3.34

1.0

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

103

712

1.46

3.31

1.1

121.82

114.87

1.43

655

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

255

1.77

3.28

2.0

1.5

5.12

6.55

u/l

1.21

220

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

550

1.52

3.28

1.3

1.4

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

423

1.59

3.27

2.5

1225.69

1014.43

0.36

423

(1001926) Buprenorphine [Presence] in Urine by Screen method

190

1457

1.31

3.26

1.8

2.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

551

1.51

3.26

1.3

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

185

1415

1.32

3.24

3.5

3.3

2.47

3.28

ratio

0.34

107

790

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

339

1.66

3.24

1.0

1.1

8.34

8.39

iu/ml

0.00

100

(3029634) Reagin Ab [Titer] in Serum by VDRL

666

1.46

3.23

2.9

2.1

2.00

13.13

titre

—

(40768443) Skin Pathology biopsy report

269

2162

1.26

3.20

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

234

1850

1.28

3.20

2.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

236

1.79

3.16

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

129

939

1.38

3.13

1.6

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

556

4809

1.17

3.13

2.2

2.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

574

1.49

3.09

1.2

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

544

1.50

3.03

1.6

1.7

535.61

371.50

mu/l

0.46

432

(3024891) Influenza virus A+B Ag [Presence] in Specimen

168

1281

1.32

3.03

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

142

1056

1.35

3.03

3.8

3.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

247

1.75

3.02

1.6

3.0

—

(3024928) Oxygen saturation in Venous blood

165

1257

1.32

3.00

3.5

3.1

63.86

62.00

0.51

160

1219

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

644

1.45

3.00

1.7

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

154

1.95

2.98

1.3

1.5

—

(3037121) Protein [Mass/volume] in Urine

199

1558

1.29

2.96

4.1

3.4

354.11

411.14

mg/l

0.29

714

(3024869) Neuronal Ab [Presence] in Serum

2.40

2.96

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

379

1.59

2.96

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

272

2213

1.24

2.94

1.1

52.50

152.84

titre

—

(21494890) Protein electrophoresis panel - 24 hour Urine

460

1.53

2.92

2.0

2.2

—

(3022621) pH of Urine by Test strip

442

3776

1.19

2.90

3.0

2.5

5.99

6.07

1.09

295

2526

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.44

2.89

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1.59

2.88

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1593

14816

1.11

2.87

5.6

5.3

2.47

3.08

ug/l

1.02

1431

13481

(3045424) Erythrocytes [Presence] in Urine

282

2310

1.23

2.87

2.2

2.1

0.01

estimate

0.19

756

(3012565) Volume of 24 hour Urine

244

1.73

2.86

2.2

1940.27

1861.45

0.22

224

(3018333) Ribosomal P Ab [Presence] in Serum

353

1.59

2.80

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

201

1.80

2.80

1.6

2.2

86.75

162.71

umol/l

0.85

102

(44813793) Dust mix specific IgE antibody measurement

322

1.62

2.80

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

151

1.93

2.79

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

209

1.78

2.77

1.1

2.00

7.41

u/ml

—

(3045142) Bone marrow Pathology biopsy report

572

1.46

2.77

1.2

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

271

2221

1.23

2.75

1.8

1.7

1.58

1.52

g/l

0.46

234

1916

(3004775) Volume in Urine collected for unspecified duration

308

1.63

2.75

2.5

2.2

715.73

618.66

0.88

208

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

166

1.87

2.75

1.3

2.3

175.32

176.42

0.02

160

(3017446) Testosterone [Moles/volume] in Serum or Plasma

475

4106

1.17

2.72

2.5

2.3

12.34

13.34

nmol/l

1.80

422

3730

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

317

1.61

2.71

1.6

1.4

20.18

20.63

u/ml

0.03

(3000093) Morphology [Interpretation] in Blood Narrative

445

1.51

2.69

1.1

—

(36660697) Celiac disease serology panel - Serum

445

3832

1.18

2.67

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

560

1.45

2.67

1.2

1.4

—

nmol/l

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

387

3295

1.19

2.66

1.2

183.13

149.62

u/ml

0.73

149

1223

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

390

1.54

2.65

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

154

1.89

2.65

1.1

92.45

88.84

0.21

(3011985) Renin [Units/volume] in Plasma

678

1.41

2.64

1.5

119.18

53.83

mu/l

0.63

610

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

273

1.65

2.64

1.8

2.0

128.61

108.16

ng/l

0.36

273

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

206

1647

1.26

2.63

1.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

376

1.55

2.60

1.8

1.6

—

(3006653) Thiamine [Moles/volume] in Blood

236

1.70

2.60

1.7

1.3

122.18

135.98

nmol/l

1.40

236

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

155

1.88

2.60

1.1

1.3

96.50

88.10

0.35

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

184

1.80

2.60

1.8

3.0

0.61

mmol/l

0.01

184

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

625

5534

1.15

2.60

5.4

4.8

31.60

32.45

1.12

431

3667

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

406

3481

1.18

2.58

1.5

1.4

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

377

1.54

2.58

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

377

1.54

2.58

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.30

2.57

1.3

1.5

—

0.71

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

466

1.49

2.57

1.3

1.2

41.00

43.32

u/ml

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

3.60

2.57

1.1

1.0

—

(3002256) Pathology report gross observation

733

6565

1.13

2.57

1.3

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.00

2.56

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

363

1.55

2.52

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

584

1.43

2.51

1.3

0.28

0.21

nmol/l

0.27

457

(3008898) HLA-B27 [Presence]

202

1622

1.25

2.50

1.1

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

621

1.41

2.44

1.3

614.49

321.82

pmol/l

0.45

534

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

196

1.74

2.42

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

196

1.74

2.42

1.3

1.4

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

117

879

1.34

2.41

1.4

1.3

33.83

39.88

u/l

0.25

107

758

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

352

1.54

2.39

1.3

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

266

1.62

2.37

12.9

13.2

0.59

0.63

mmol/l

0.54

241

(3004616) Nuclear Ab [Presence] in Serum

575

1.41

2.36

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

251

1.64

2.36

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

162

1.79

2.30

1.2

1.4

80.52

308.40

nmol/24h

0.71

162

(3036670) Protein [Mass/volume] in Synovial fluid

119

1.94

2.30

1.5

1.3

44.75

39.84

g/l

—

(3039443) Prostate specific Ag panel - Serum or Plasma

909

0.69

2.29

2.0

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

163

1.78

2.26

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

242

2006

1.22

2.26

1.7

0.22

0.32

mg/l

3.19

110

948

(3013727) Leukocytes other/Leukocytes in Blood

134

1.87

2.26

5.7

3.3

49.88

53.02

0.27

129

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

193

1.71

2.25

5.7

3.2

0.95

1.38

0.94

193

(4198724) Urine methamphetamine measurement

186

1.72

2.23

1.5

2.9

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

391

1.49

2.22

1.4

1.3

47809.08

109877.76

e6/l

0.85

258

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

383

1.49

2.22

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

187

1.72

2.20

1.1

90.15

94.03

0.28

150

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.41

2.19

1.5

1.3

—

(44806071) Cardiolipin IgM antibody measurement

2.41

2.19

1.2

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

393

1.48

2.18

1.3

1.2

72.00

49.20

u/ml

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

443

1.45

2.16

1.2

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

3.00

2.14

2.0

1.6

2.28

1.46

mg/l

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.30

2.14

1.6

2.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.10

2.12

1.0

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.05

2.11

2.0

1.8

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

413

1.46

2.09

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

666

1.36

2.09

1.1

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.71

2.06

1.1

1.2

5.00

18.62

u/l

—

(3042631) Mycobacterium sp identified in Specimen

625

1.37

2.06

2.3

2.9

—

(3000330) Specific gravity of Urine by Test strip

276

2341

1.19

2.05

3.8

3.3

1.02

ratio

0.17

240

2107

(3004451) EKG impression Narrative

254

1.58

2.03

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

2.50

2.01

2.0

1.3

4.97

5.60

mmol/l

—

(37208534) Antinuclear antibody arbitrary concentration in serum

140

1.79

2.00

1.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

733

1.33

1.98

1.1

1.2

1.16

0.70

—

(3006270) Folate [Moles/volume] in Blood

369

1.47

1.97

1.2

1.1

387.09

371.65

nmol/l

0.21

319

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

436

1.43

1.96

1.1

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.97

1.93

2.6

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

2.12

1.92

3.3

2.9

32.03

32.84

mg/l

—

(3012501) Base excess in Blood by calculation

124

976

1.28

1.89

3.8

4.4

2.27

2.66

mmol/l

0.95

647

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1268

11877

1.09

1.89

4.4

4.3

22.97

21.99

1.43

610

5785

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

188

1554

1.22

1.86

1.8

1.9

41.81

41.31

nmol/l

0.09

181

1516

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

2.65

1.86

1.2

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.86

1.86

1.1

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

2.86

1.86

1.0

0.04

0.20

u/ml

—

(1002224) Polysomnography panel

278

2383

1.18

1.85

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.39

1.85

1.1

0.02

u/ml

0.16

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

318

1.48

1.82

1.4

1.6

—

(3047189) Immunofixation for 24 hour Urine

214

1.59

1.81

1.6

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

107

832

1.29

1.81

1.8

1.6

—

(3014271) Vancomycin [Susceptibility]

208

1.59

1.76

2.7

2.9

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

688

1.31

1.73

1.3

1.4

0.13

0.28

nmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

289

2501

1.16

1.73

1.0

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

155

1.68

1.72

2.0

2.7

234.53

135.17

au/ml

—

(3020393) Adenovirus Ag [Presence] in Stool

2.29

1.70

1.3

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

1.91

1.69

1.0

1.2

294.83

292.34

pmol/l

0.01

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

183

1527

1.21

1.68

4.8

3.5

1.60

1.51

mg/l

0.67

161

1403

(42529582) MDA5 Ab [Presence] in Serum by Line blot

141

1.71

1.67

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

141

1.71

1.67

1.1

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

141

1.71

1.67

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

141

1.71

1.67

1.1

1.0

—

(3022806) Fractional oxyhemoglobin in Capillary blood

571

1.34

1.66

1.9

1.8

89.08

89.69

0.29

563

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.16

1.66

5.0

1.8

—

(3051101) Glucose [Moles/volume] in Cord blood

2.03

1.64

4.4

6.3

8.85

8.01

mmol/l

0.42

(3020717) Zinc [Moles/volume] in Serum or Plasma

294

1.47

1.62

1.3

1.5

22.09

23.79

umol/l

0.13

269

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

272

2358

1.16

1.61

2.5

2.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

214

1.55

1.59

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

296

1.46

1.57

6.6

7.3

5.77

89.63

ug/l

0.86

196

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

648

1.30

1.55

2.0

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.88

1.54

1.8

2.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

248

1.50

1.54

10.9

6.1

39.17

800.96

u/ml

0.63

(3033099) Centromere Ab [Titer] in Serum

107

1.78

1.54

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

130

1.70

1.52

1.5

1.6

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

2.59

1.51

3.1

1.5

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

651

1.29

1.50

1.0

1.1

8.19

2.21

0.53

116

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

226

1.51

1.48

1.2

1.7

3.00

7.13

nmol/l

0.89

177

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

445

1.35

1.46

5.3

5.7

119.74

56.48

u/ml

0.36

141

(3042517) Benzodiazepines panel - Urine

2.22

1.46

2.3

2.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

567

1.31

1.45

2.4

2.5

86.83

25.21

iu/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.50

1.45

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

596

1.30

1.41

1.2

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

354

1.39

1.41

2.0

1.8

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

173

1.56

1.39

1.0

1.1

3.58

6.35

u/ml

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

119

1.68

1.37

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

264

1.44

1.36

2.0

2.1

8.06

8.11

mmol/l

0.03

264

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

957

8991

1.08

1.33

3.2

0.82

0.77

ug/l

0.40

624

5778

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

553

5078

1.10

1.32

1.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

348

3121

1.12

1.30

2.5

2.1

—

(3017569) Oxygen content in Arterial blood

267

1.43

1.29

2.3

2.4

15.68

16.21

0.42

267

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.76

1.28

1.6

2.5

4.50

366.54

ug/l

0.61

(3003694) ABO and Rh group [Type] in Blood

1477

14106

1.06

1.28

1.5

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.09

1.27

1.2

1.0

—

(3023419) Bacteria identified in Sputum by Culture

606

1.27

2.5

2.6

—

(3032057) Clostridioides difficile [Presence] in Stool

1.79

1.27

1.1

2.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

143

1204

1.19

1.26

1.1

15.96

8.16

eliau/ml

0.26

167

(3020191) Ethanol [Moles/volume] in Serum or Plasma

380

1.35

1.24

1.8

1.3

1.10

1.22

promille

0.23

300

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

125

1041

1.21

1.24

1.4

1.5

—

(21494434) Karyotype in Bone marrow

432

1.32

1.24

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

796

1.24

1.3

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

433

1.32

1.23

2.3

2.8

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.63

1.21

1.2

1.1

317.20

262.02

nmol/l

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.63

1.21

1.0

0.05

u/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

547

5047

1.09

1.19

3.7

4.4

58.56

23.15

ug/l

0.35

452

4078

(40761539) Cells [Type] in Urine sediment by Light microscopy

101

1.69

1.19

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.31

1.18

13.0

8.2

—

(3046861) Legionella sp Ag [Presence] in Urine

2.31

1.18

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

250

0.60

1.18

1.0

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

125

1.60

1.17

1.2

—

(40758292) HTLV I+II Ab panel - Serum

102

1.67

1.16

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

240

1.42

1.15

1.3

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

177

1534

1.16

1.13

1.4

1.3

229.89

225.93

miu/ml

0.05

714

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

216

1.44

1.13

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

457

1.29

1.13

3.2

3.4

16.94

13.04

index

1.35

276

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

798

7498

1.08

1.13

1.5

—

(4034850) Laboratory test

165

1424

1.16

1.12

10.2

9.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.90

1.12

1.1

—

(3016750) Collection duration of Urine

225

1.42

1.11

2.7

2.2

520.40

488.15

min

1.13

169

(4024509) Urine culture

239

2122

1.13

1.09

2.1

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.38

1.09

1.4

1.5

821.40

517.44

nmol/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

104

1.64

1.09

1.4

1.5

—

(3014891) Appearance of Pleural fluid

1.87

1.07

1.5

1.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

373

0.70

1.06

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.52

1.05

2.1

2.5

10.45

10.43

kpa

0.01

145

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

1.52

1.05

2.1

2.5

4.84

4.85

kpa

0.02

145

(3005033) Fetal Nuchal fold Thickness US

968

0.81

1.05

1.5

1.25

1.26

0.07

684

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1011

0.82

1.04

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

158

1369

1.16

1.04

2.0

4.65

7.90

iu/l

0.38

589

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.96

1.03

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

130

1.54

1.02

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

196

1.43

1.02

2.4

2.5

56.70

51.85

umol/l

0.25

174

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

247

1.38

1.01

1.8

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

247

1.38

1.01

1.8

1.6

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.84

0.98

1.0

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

2.17

0.98

5.2

2.7

2.39

2.20

mg/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.95

0.97

1.1

1.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

776

1.20

0.96

1.4

0.28

0.39

nmol/l

1.07

588

(3032868) Hemoglobin electrophoresis panel in Blood

1.85

0.96

1.1

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.96

0.0

1.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

0.00

0.96

0.0

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

363

1.30

0.95

1.3

0.38

1.46

u/ml

1.44

207

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

363

1.30

0.95

1.1

1.2

80.00

200.85

titre

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

284

2574

1.11

0.94

2.4

2.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

209

1.39

0.92

4.2

5.0

60.00

63.87

mg/l

0.15

149

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.82

0.92

1.0

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

162

1423

1.14

0.91

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

223

2483

0.89

0.91

1.6

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

393

1.27

0.90

2.0

1.5

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

102

1.57

0.90

1.1

1.2

14.25

33.85

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

227

1.37

0.90

1.2

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

253

1.35

0.90

1.2

1.7

118.53

466.36

pmol/l

—

(40768446) Kidney Pathology biopsy report

185

1.41

0.89

1.9

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

211

1.38

0.88

2.0

98.80

213.42

ug/min

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

124

1072

1.16

0.87

1.1

1.95

2.27

u/ml

0.16

567

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

298

1.31

0.87

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.86

0.87

1.1

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

169

1.42

0.87

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

2.00

0.87

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

300

1.30

0.84

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

137

1.46

0.84

1.4

1.5

10.37

9.10

ug/l

0.50

137

(3047352) Trisomy 18 risk [Likelihood] in Fetus

984

0.84

0.83

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.76

0.83

1.1

—

(3020491) Glucose [Moles/volume] in Blood

318

1.29

0.83

2.5

2.1

6.98

6.49

mmol/l

0.53

219

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

328

1.28

0.81

2.2

2.0

0.92

1.34

u/field

0.87

170

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

136

1192

1.14

0.81

1.8

1.9

199.06

204.76

pmol/l

0.30

126

1131

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

223

1.35

0.81

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

346

1.27

0.81

1.0

714.40

722.67

ng/l

0.05

235

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

136

1194

1.14

0.80

2.6

1.9

—

(3019174) dRVVT (LA screen)

1.82

0.79

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

103

887

1.16

0.79

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

103

887

1.16

0.79

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

348

1.27

0.78

1.0

40.86

41.57

ng/l

0.05

241

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

199

1.36

0.78

1.7

1.33

3.47

u/field

1.21

148

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

494

1.22

0.76

1.2

41.83

63.76

u/l

5.12

431

(21494755) Public health laboratory ask at order entry panel

438

4676

0.93

0.75

1.3

1.4

—

(3006462) Nitrate [Presence] in Urine

192

1.36

0.74

3.6

3.3

—

(3000012) Reticulocyte production index

688

1.18

0.74

1.8

2.2

0.90

0.88

0.08

464

(3024932) HLA-DR beta [Type]

141

1.42

0.74

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.84

0.73

1.3

—

(3024316) Viscosity of Plasma

2.00

0.72

1.0

1.7

—

1.87

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.0

—

(3001556) Androgen free Index in Serum or Plasma

1.80

0.72

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

335

1.26

0.71

1.1

13.14

19.21

u/ml

0.63

149

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

140

1244

1.13

0.71

1.3

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

673

1.18

0.71

5.3

5.6

377.55

360.75

umol/l

0.48

583

(3004716) Salmonella sp identified in Stool by Organism specific culture

241

2208

1.10

0.70

1.4

—

(40768795) Lymph node Pathology biopsy report

490

1.21

0.70

1.3

1.2

—

(4211845) Urine protein measurement

212

1.32

0.70

3.8

3.2

—

(3024471) HLA-A [Type]

143

1.40

0.70

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

346

1.24

0.68

1.0

318.11

315.94

ng/l

0.02

243

(44806420) Estimation of glomerular filtration rate

547

1.19

0.68

2.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

294

1.26

0.66

1.0

—

(1761868) Lipid panel - Serum or Plasma

1850

18957

0.96

0.65

3.3

3.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.59

0.65

2.3

2.4

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

109

961

1.14

0.64

4.1

3.2

24.76

26.82

mg/l

0.23

654

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

181

1.33

0.63

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

673

1.16

0.62

2.6

2.8

5126.22

424.22

u/ml

0.70

663

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.61

1.2

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

480

1.19

0.61

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

111

1248

0.89

0.60

1.5

64.14

60.57

ug/l

0.36

1026

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

218

1.29

0.60

2.1

2.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.50

0.59

3.1

3.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.58

0.0

1.0

—

0.08

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

1.72

0.57

1.7

2.2

2.45

2.69

mg/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.43

0.56

1.1

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

347

1.21

0.56

1.5

1.4

148.22

193.28

pmol/l

0.84

347

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.62

0.55

4.3

2.7

0.33

0.68

u/field

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

607

1.16

0.55

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

168

1.31

0.54

4.9

4.8

—

(3044007) Cell count panel - Peritoneal fluid

168

1.31

0.54

1.7

1.9

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

163

1782

0.91

0.54

1.1

0.75

0.64

ratio

0.55

230

(3020874) Milk IgE Ab [Units/volume] in Serum

303

1.22

0.54

1.0

1.1

0.16

2.50

u/ml

1.10

(3014765) Yersinia sp identified in Stool by Organism specific culture

138

1252

1.10

0.53

1.3

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.54

0.53

1.3

1.7

36.83

43.18

umol/l

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

108

1.39

0.53

1.0

1.1

—

11.20

u/ml

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.52

0.52

1.0

1.5

—

(40768800) Prostate Pathology biopsy report

970

0.88

0.52

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

601

1.15

0.52

1.8

1.4

2.93

3.73

ug/l

0.67

537

(3003888) Timothy IgE Ab [Units/volume] in Serum

105

943

1.12

0.50

1.1

5.43

5.09

u/ml

0.08

497

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.49

0.49

1.3

1.4

0.40

1.91

mmol/l

—

(3024263) Appearance of Synovial fluid

225

1.25

0.49

1.8

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.43

0.49

1.0

1.2

0.73

0.69

umol/24h

—

(3025130) Human papilloma virus identified in Specimen

755

1.13

0.49

1.6

1.9

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

289

1.21

0.48

1.2

15.55

28.89

u/l

1.69

237

(3035320) C reactive protein [Mass/volume] in Body fluid

372

1.18

0.48

3.1

2.4

18.52

30.70

mg/l

2.50

266

(42529406) Shigella sp [Presence] in Stool by Culture

138

1261

1.10

0.48

1.3

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

328

1.19

0.46

1.9

1.4

—

(3017704) Immunofixation for Urine

228

1.23

0.45

1.4

1.6

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

104

1147

0.90

0.44

1.4

1.5

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.61

0.43

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.43

0.42

1.1

—

(4281824) Cell count and differential, peritoneal fluid

542

0.87

0.42

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

576

1.13

0.41

1.4

1.5

3202.38

4118.75

e6/l

0.19

391

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.41

0.0

1.0

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.40

0.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.47

0.40

1.0

1.3

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.47

0.40

1.0

1.1

—

41.81

—

(40768441) Liver Pathology biopsy report

380

1.16

0.40

1.5

—

(3025577) Chromium [Mass/volume] in Blood

232

1.21

0.39

2.2

1.86

2.31

ug/l

0.47

201

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.31

0.39

1.4

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.43

0.39

1.4

1.7

271.20

363.57

umol/24h

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

297

1.18

0.39

1.2

81.76

96.07

u/l

0.54

247

(3014599) Egg white IgE Ab [Units/volume] in Serum

297

1.18

0.39

1.1

0.93

0.94

u/ml

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

1.41

0.39

1.1

1.0

89.35

78.82

ug/l

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

1.34

0.38

13.9

9.6

7.31

5.55

mmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

723

1.11

0.37

1.1

3.85

3.87

u/ml

0.00

317

(4094501) Cardiovascular stress test using bicycle ergometer

123

1331

0.92

0.37

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

299

1.17

0.37

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

182

1708

1.07

0.37

2.4

1.8

4.92

4.73

mg/l

0.06

143

1244

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.29

0.36

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

608

0.89

0.36

1.3

7.26

7.31

mmol/l

0.05

544

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

146

0.75

0.36

1.2

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

107

1160

0.92

0.35

1.5

1.30

1.18

ratio

0.52

697

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

107

1160

0.92

0.35

1.5

0.96

0.95

ratio

0.14

693

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

107

1159

0.92

0.34

1.5

1.33

1.16

ratio

0.85

692

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

246

1.18

0.34

1.1

1.3

5.83

4.87

umol/l

0.60

217

(3023487) Leukocytes [#/volume] in Peritoneal fluid

191

1.21

0.33

1.7

2.1

1353.44

742.92

e6/l

0.31

134

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

162

1721

0.94

0.32

1.5

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

1.33

0.32

1.5

1.3

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

612

0.90

0.31

2.5

2.7

13.26

13.13

0.47

603

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.29

0.30

1.8

1.9

21.90

16.31

umol/l

0.88

(40761995) Spermatozoa Progressive [#/volume] in Semen

107

0.75

0.29

2.9

3.3

47.25

43.26

—

107

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

107

0.75

0.29

5.8

6.6

7.62

8.31

—

107

(40765089) Chromosome analysis panel - Blood by G-banded

130

1.23

0.28

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

873

1.08

0.28

1.1

0.77

1.48

u/ml

0.84

442

(3028717) Thiamine [Mass/volume] in Blood

1.27

0.27

1.1

1.2

71.25

65.35

ug/l

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

113

1.24

0.26

7.1

7.3

8.46

5.45

kpa

1.04

113

(3008401) Mugwort IgE Ab [Units/volume] in Serum

915

1.07

0.26

1.1

1.57

1.20

u/ml

0.25

397

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.28

0.26

1.4

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.70

0.26

1.4

8.80

563799.22

nmol/l

—

(3012441) Differential panel - Pleural fluid

502

1.10

0.25

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

105

1.24

0.24

1.1

1.0

29.82

40.06

iu/ml

0.32

105

(3050129) First trimester maternal screen panel - Serum or Plasma

133

1403

0.95

0.24

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

124

1.21

0.24

1.0

1.1

0.44

9.14

u/ml

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

265

1.13

0.23

1.1

1.0

0.64

1.72

u/ml

—

(3001729) Color of Synovial fluid

1.32

0.23

2.0

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.28

0.23

1.0

1.3

2.78

1.67

umol/24h

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1.28

0.23

1.0

1.2

—

12.94

—

(3043410) Blood group antigens tested for on Red Blood Cells

134

1.19

0.22

2.4

1.8

—

(3050794) Legionella sp Ab [Presence] in Serum

1.25

0.22

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

153

1.18

0.22

1.3

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

796

1.07

0.22

1.8

1.7

—

(36303858) Crystals [Presence] in Urine

0.00

0.21

0.0

1.1

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

0.21

0.0

11.4

—

60.60

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.21

0.0

2.2

—

26.87

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.1

—

(3045788) Cell count panel - Pleural fluid

478

1.09

0.21

1.4

1.5

—

(40768806) Pleura Pathology biopsy report

513

0.92

0.21

1.6

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

9.8

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

1.80

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

173

1.16

0.20

1.8

2.1

44.78

65.20

ug/l

0.81

168

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.21

0.19

1.1

1.4

1.17

1.18

mmol/l

0.25

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

109

1.19

0.18

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

164

0.85

0.18

1.6

1.9

—

(3000034) Microalbumin [Mass/volume] in Urine

386

1.09

0.18

4.0

3.2

74.85

52.23

mg/l

0.24

289

(3000919) Neutrophils/Leukocytes in Pleural fluid

128

1.17

0.18

1.1

1.4

20.87

21.53

0.03

119

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

309

1.10

0.18

2.1

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

658

1.06

0.18

1.1

0.29

0.24

u/ml

0.08

214

(4133840) Spirometry

110

1.18

0.17

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

514

1.07

0.16

1.4

111653.29

68839.38

e6/l

0.31

275

(3044927) Protein electrophoresis panel - Urine

418

1.08

0.16

1.2

1.1

—

(3020650) Glucose [Presence] in Urine

187

1.12

0.15

1.4

1.7

0.00

0.03

estimate

0.80

187

(3005011) Chlamydia sp Ab [Titer] in Serum

0.78

0.15

1.7

1.6

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

130

1.15

0.15

1.1

1.2

192.64

427.41

ug/l

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

604

1.06

0.15

2.0

2.1

5.91

7.83

umol/l

0.71

436

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.11

0.15

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.11

0.15

1.1

1.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.11

0.15

1.1

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

1.10

0.15

5.9

7.1

12.17

10.56

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

217

1.11

0.14

1.3

1.2

8.88

9.46

mm/h

0.16

217

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

179

1.12

0.14

1.5

1.6

41.38

39.96

g/l

0.72

179

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.82

0.13

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

668

1.05

0.12

1.4

1.5

32.40

32.76

g/l

0.09

602

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

290

0.93

0.10

1.4

1.6

7.11

5.88

u/l

0.28

234

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

211

2154

0.98

0.10

1.6

1085.42

1014.88

mu/l

0.46

176

1799

(40757373) Influenza virus identified in Isolate

1.15

0.09

1.8

1.7

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.04

0.09

1.0

1.1

16.52

16.88

g/l

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

184

1802

1.02

0.09

2.8

3.6

747.61

3169.29

u/ml

0.81

156

1554

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.82

0.08

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

166

1.08

0.07

1.0

1.2

—

(3048879) Bone marrow aspiration report

122

0.90

0.07

1.7

1.8

—

2.00

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

106

1038

1.02

0.06

1.6

—

(3002619) Bacteria identified in Specimen by Culture

119

1.09

0.06

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

119

1.09

0.06

4.5

3.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

255

2525

1.01

0.04

3.5

3.8

43.48

64.67

u/ml

1.28

242

2438

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

298

1.04

0.04

2.2

1.5

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

576

1.02

0.04

1.2

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

111

1.08

0.04

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

915

1.02

0.03

1.9

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

915

1.02

0.03

3.7

3.3

0.76

0.80

nmol/l

0.59

733

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

657

1.02

0.03

1.1

3.78

3.23

eliau/ml

0.17

312

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

429

0.98

0.02

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

238

0.97

0.02

3.9

4.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

801

1.01

0.01

1.5

55.90

60.79

ug/l

0.58

801

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

167

0.96

0.01

1.4

1.9

4726.78

20238.22

e6/l

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

164

1.04

0.00

2.4

2.2

8.05

9.38

mg/l

—

136

(3041806) Other cells [#/volume] in Blood by Manual count

142

0.99

0.00

1.9

1.6

0.55

0.50

e9/l

0.51

142

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

202

0.99

0.00

1.9

2.6

204.70

149.98

nmol/l

0.41

178

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

208

1.01

0.00

1.7

1.9

0.49

1.58

u/ml

—

(3036071) Salmonella sp Ab [Titer] in Serum

165

0.97

0.00

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

478

1.00

0.00

3.1

3.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

104

1038

1.00

0.00

3.2

3.7

42.91

698.57

u/ml

1.88

951

(40768793) Breast Pathology biopsy report

119

1185

1.00

0.00

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

147

1.02

0.00

1.0

1.4

14.59

12.75

g/l

—

111

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

281

1.00

0.00

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

769

1.00

0.00

1.1

4.42

3.82

u/ml

0.10

377

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.0

—

0.28

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.0

1.2

—

40.14

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

0.00

0.0

1.2

—

86.40

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.02

-0.00

1.3

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.89

-0.00

1.7

2.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.99

-0.00

1.6

2.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

-0.00

0.0

7.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

1.02

-0.00

1.8

1.5

—

(3034426) Prothrombin time (PT)

170

1.00

-0.00

1.1

1.2

29.47

28.57

0.22

170

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.00

-0.00

0.0

1.1

—

168.50

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

-0.00

0.0

1.0

—

1.50

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.94

-0.00

4.3

2.6

48.52

86.18

pmol/l

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.93

-0.00

3.8

9.9

0.18

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.1

—

66.87

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_BELLPA and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.24 [1.13, 1.36]	< 0.001
Birth year	0.995 [0.99, 1.0]	0.21

During the follow-up period (1.1.1998 — 31.12.2019), 2774 out of 16681 females with G6_BELLPA died.

Males

Parameter	HR [95% CI]	p-value
G6_BELLPA	1.149 [1.05, 1.26]	0.004
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2668 out of 15120 males with G6_BELLPA died.

Mortality risk

Mortality risk for people of age

years, who have G6_BELLPA.

N-year risk	Females	Males
1	0.126%	0.226%
5	0.737%	1.389%
10	1.735%	3.341%
15	3.486%	6.307%
20	5.89%	10.913%

Relationships between endpoints

↥

Index endpoint: G6_BELLPA – Bell's palsy

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Bell's palsy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints